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Biocatalysts offer advantages over their chemical counterparts in terms of their 
high enantioselectivity and the opportunity to develop more environmentally friendly 
processes.  However, the widespread adoption of biocatalytic processes is hampered by 
the long development times for enzymes with novel and sufficient activity and adequate 
stability under operating conditions.  Protein engineering, while extremely useful for 
modifying the properties of protein catalysts in select cases, still cannot be performed 
rapidly enough for many applications.  In order for biocatalysts to become a competitive 
alternative to chemical catalysts, new tools to make the tailoring of biocatalysts by 
protein engineering methods speedier and more efficient are necessary.  The aim of this 
work was to develop methods to aid in the faster production of novel biocatalysts.  
Protein engineering involves two steps:  the generation of diversity and the 
screening or selection of variants with the desired properties.  Both of these must be 
targeted to create a faster protein engineering process.  In the case of the former, this 
work sought to clone and overexpress some template enzymes which would create 
smaller, more manageable libraries of mutants with a higher likelihood of function by the 
manipulation of a few focused amino acid residues.  For the latter, this work developed 
and validated a Monte-Carlo simulation model of pooling to increase screening 
throughput and created a set of vectors to aid in high-throughput screening by eliminating 





INTRODUCTION:  TOOLS AND TRICKS TO ACCELERATE THE 
DEVELOPMENT OF NOVEL BIOCATALYSTS 
 
 
Biocatalysis, or the use of whole cells or enzymes to perform chemical reactions, 
is becoming increasingly useful on a large scale.  Processes utilizing biocatalysts are 
often more environmentally friendly than the chemically catalyzed alternatives and the 
selectivity of biocatalysts (both regioselectivity and enantioselectivity) leads to a 
reduction in both starting material required and waste produced.  However, biocatalysts 
were evolved to work in the cellular environment; aqueous medium at low temperatures 
and near neutral pH, and these conditions may not be identical to the conditions 
necessary to carry out the desired reaction on a large scale.  Thus, the field of protein 
engineering has emerged to improve the properties of biocatalysts to become more 
compatible with operating conditions. 
Protein engineering involves both rational and combinatorial methods of changing 
a protein sequence to achieve a desired result, such as a change in substrate specificity, or 
increased stability to temperature, organic solvents, and/or extremes of pH.  Rational 
methods, such as site-directed mutagenesis, require targeted amino acid substitutions, and 
therefore, require a large body of knowledge about the biocatalyst being improved, 
including the three-dimensional structure and the chemical mechanism of the reaction.  
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The main advantage to rational design is that a very small number of protein variants are 
created, meaning that very little effort is necessary to screen for improved properties.  
Combinatorial methods, on the other hand, create a large number of variants that must be 
assayed, however they have the advantage of not requiring such extensive knowledge 
about the protein.  In addition, often times non-obvious changes in the protein sequence 
will lead to large improvements in their properties, these are extremely hard to predict 
rationally, and thus, can only be identified by combinatorial methods. 
Although protein engineering, particularly via combinatorial methods, has 
become a useful tool to improve the utility of biocatalysts, one of the challenges 
hampering the widespread implementation of biocatalytic processes is the development 
time necessary to tailor the biocatalyst to the operating conditions.  Many of the 
biocatalytic processes currently in operation, such as the biological route to acrylamide 
and similar processes (discussed briefly in Chapter II) took decades to develop.  Such a 
large resource investment, coupled with the fact that the lifetime of patent protection is 
only about as long as the development time, has hindered development of biocatalytic 
processes for many industrially relevant problems.  The work presented here seeks to 
decrease the development times for new biocatalysts by accelerating the process of 
protein engineering.  In the future, these tools can be used to create biocatalytic routes to 
products formerly inaccessible by biological routes and will increase the efficiency of 
protein engineering efforts. 
Combinatorial methods of protein engineering involve two main steps, the 
generation of diversity, followed by the screening or selection of the variants created to 
identify which have the improved properties of interest.  Chapters III through V focus on 
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shortening the development time of new biocatalysts by focusing on improving the 
identification of improved mutants.  The screening process involves the individual assay 
of each mutant created, and as a consequence, is very resource- and time-intensive.  
Chapters III and IV deal with the development and experimental validation of a Monte-
Carlo simulation model of pooling to increase the throughput in screening assays.  
Pooling, a concept used in the screening of combinatorial chemical libraries, is a two-
stage process.  In the first stage, multiple cells are combined into a single assay well, 
forming a pool.  The best pools are chosen for the second stage where they are separated 
into individual cell types and assayed to extract the improved mutant.  Pooling for 
combinatorial protein engineering problems depends on several factors including the 
frequency with which good mutants are created, the increase in activity level of the most 
highly improved mutants, the level of accuracy of the assay, and the distribution of 
activity levels in the population.  Chapter III focuses on the initial validation of the model 
using highly controlled systems designed to test the simulations at various levels of the 
factors mentioned previously by mixing known entities with varying levels of activity 
towards the hydrolysis of substrates containing a galactoside moiety.  The first system 
tested was a binary mixture of a very highly active mutant (the"supermutant") with an 
ancestral cell (the "dud").  Because the difference in activity level of the supermutant and 
dud was far larger than the error in assay detection we were able to provide additional 
validation by using the Poisson distribution to directly calculate the number of active 
mutants for this case.  We then moved to a more realistic case where the population 
remained binary, but the difference in activity level was much lower, more realistic for a 
protein engineering experiment.  Finally, we tested the performance of the model on a 
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simulated activity curve using cells with activity level ranging from zero to 15-fold over 
the ancestral cell. 
Following the initial validation of the Monte Carlo model in Chapter III, Chapter 
IV extends the prediction to an actual directed evolution library, created by 
randomization of the active site in three amino acid residues.  Here, we also use a system 
that requires induction of protein expression (rather than the constitutively expressing 
system in Chapter III), a situation more common to protein engineering projects.  The use 
of pooling in this more realistic example increases the number of good mutants detected, 
and the simulation model accurately predicts the number of mutants expected.  Pooling is 
a valid method to increase the throughput of high throughput screening assays.       
The process of analyzing the protein variants for the activity of interest requires 
the transformation of cells with the DNA of interest usually carried on a plasmid (vector), 
which also serves as a means to express the protein.  Chapter V discusses the creation of 
vectors designed to aid protein engineering efforts by combining state-of-the-art features 
that have been shown in the literature to increase the efficiency of high throughput 
screens and selections.  Among these is the use of reporter proteins to indicate which 
mutants are successfully expressed as well as to provide a basis for normalization by 
expression levels, the use of ligation-independent cloning to insert the gene of interest 
with high efficiency and regardless of the restriction pattern of the gene, the use of the 
bacterial inhibitor triclosan to provide stringent selection for plasmid retention, and 
protein expression controlled by the Tn(10) tet promoter/operator which is orthogonal to 
the metabolism of the traditional E. coli expression strains.  The combination of these 
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features into one vector allows for the optimal expression and screening of protein 
variants in a high throughput manner. 
The focus of Chapter VI is to increase the efficiency of protein engineering 
experiments by impacting the diversity generation steps.  We introduce the concept of the 
α/β-barrel protein as a generic scaffold for enzyme evolution and present the cloning and 
overexpression of enolase from three organisms as a template for further evolution. The 
α/β-barrel is a ubiquitous fold found in nature, consisting of eight alternating alpha 
helices and beta strands which pack to form an inner core of beta strands surrounded by 
an outer core of alpha helices.  All catalytic residues are found in the loop regions.  This 
fold is especially suited as a scaffold template because a large portion of the amino acid 
residues can be eliminated from diversity generation because they form the secondary 
structure of the enzyme and, in addition, the loop regions which are responsible for 
catalysis are localized at the C-terminal end of the barrel.  Thus, protein engineering 
efforts can be focused in one particular region, which increases the likelihood for activity 











Biocatalysis, the use of whole cells or isolated enzymes for chemical 
transformations, has been employed for thousands of years, beginning with early 
civilizations which used yeast to leaven bread and ferment beverages.  During the past 
few decades the industrial use of ‘white biotechnology’ is increasing substantially and the 
trend is expected to continue.2   
2.1.2 Advantages 
The biggest advantage of biocatalysts involves the synthesis of products 
containing chiral centers.  Here, biocatalysts not only have an advantage in that they are 
highly regio- and stereo- selective, but they also avoid the need of multiple protection and 
deprotection steps commonly found in organic syntheses and are less likely to produce 
unwanted side products than traditional chemical catalysts.  In particular, the elimination 
of the protection/deprotection steps increases the atom efficiency of a process and 
decreases the amount of waste generated.3  An additional attractive feature of enzyme 
catalysts is that they work under very gentle conditions (aqueous media at ambient 
temperature); however, this is not always feasible for the process.3-5  Finally, with the 
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cost of drug development skyrocketing and an FDA mandate that each enantiomer of a 
compound be tested for safety and efficacy, biocatalysts are becoming increasingly 
important to the pharmaceutical and agrochemical industries.6   
2.1.3 Disadvantages 
The main disadvantages of biocatalysts stem from the natural evolution of their 
activity.  Enzymes have evolved to work in the cellular environment, and therefore are 
not usually tolerant to the presence of organic solvents, extremes of pH, or extremes of 
temperature.  Also, because of regulation mechanisms within cells, they may be subject 
to substrate or product inhibition.  Additionally, they have evolved to catalyze reactions 
which are useful to living organisms—these may not be the same reactions or substrates 
that are industrially useful.3-5   
2.1.4 Uses 
Biocatalysis is being used increasingly in various industrial applications, ranging 
from adding pure enzyme to a product, as is the case with detergents, or using whole cells 
to do complex syntheses in the pharmaceutical and fine chemical industry.  Overall, the 
biggest successes have come where the required enzyme is easily obtainable from the cell 
lysate, easily immobilized, catalyzes a reaction which does not require a cofactor, and the 
reaction conditions for the process are similar to the reaction conditions in vivo.5 
In the manufacturing arena, biocatalysts are used extensively in the textile 
industry, for leather processing, and as additives to detergents.7  The majority of these 
enzymes are hydrolases, hydrolyzing the bonds of proteins, lipids, and starches for 
various purposes.  In a few instance, oxidoreductases are also being employed, primarily 
as bleaching agents.  The main reason for the use of enzymes in these manufacturing 
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areas is their ease of use (e.g. in the leather industry the hide can be simultaneously 
softened, degreased, dehaired, and rehydrated in a single step) and the reduction of waste 
from chemical processes (e.g. enzymatic removal of excess dyes in the textile industry 
reduces the water usage associated with repeated rinsing).  
2.1.4.1 Enzymes in Detergents 
The addition of enzymes to detergent formulations has been in practice since the 
1960s.  Here, the function of the enzymes is to degrade the insoluble, usually polymeric, 
stains on clothing to smaller, more water-soluble monomers that can be removed into the 
washing water.  The most prevalent and first enzyme group to be added to detergents is 
the protease, which hydrolyzes proteinaceous stains, although increasingly lipases (which 
degrade fats), cellulases (for grass stains), and amylases (which degrade starches) are also 
being used.  The primary challenge in the use of enzymes as detergent additives is their 
stability in the washing environment which includes a fairly alkaline pH, the presence of 
bleaching agents and chelators, and strong surfactants.7  Therefore, a lot of time and 
effort has gone into engineering more stable versions of these enzymes with improved 
washing performance. 
2.1.4.2 Enzymes in Textile Processing 
 The most ubiquitous enzyme in the textile industry is cellulase, which hydrolyzes 
the endo, β- linkages of glucose that form the cellulose polymer.  The primary focus is to 
improve the characteristics of the cloth by polishing stray cotton fibers to decrease 
pilling, increase the softness and flexibility, and to prepare the cloth to receive dyes.  An 
additional use of cellulases is in enzymatic stone-washing, whereby fibers of the denim 
cloth that has already been dyed with indigo are selectively removed to create the mottled 
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finish characteristic of stone-washed jeans.  In 80% of cases, this process has replaced the 
original method of stone-washing that involved laundering denim fabric with pumice 
stones.  One other use of enzymes in the textile industry is the removal of excess dye and 
bleaching agents by peroxidases and catalases, respectively.7      
In the tanning industry, enzymes are used to degrease and soften the hides to 
make them ready for the tanning process.  Degreasing is performed by lipases, whereas 
softening, dehairing, and pickling are done by proteases.  These are used in conjunction 
to efficiently process the leather in a minimum number of steps.7 
2.1.4.3 Enzymes to Produce Food and Fragrance Compounds 
Many food and fragrance compounds are synthesized biocatalytically.  Due in 
part to the ‘chemophobic’ nature of the public when it comes to articles associated with 
their food source, naturally derived flavor compounds are sold for substantially higher 
prices (up to two orders of magnitude compared to their chemically synthesized 
counterparts).8   However, their extraction from natural sources is time-consuming and 
expensive.9  One advantage of biocatalytic routes to these compounds stems from the 
definition of the word ‘natural’ in the regulation of food products by the United States 
and the European Union which allows for the labeling of a product as natural as long as it 
is made via natural routes, regardless of whether this takes place in a living organism or 
in a reactor.   Additionally, biocatalytic processes are highly regio- and stereo- selective 
and can be run under fairly mild conditions to protect the often unstable compounds from 
degradation, all of which is important for maintaining their flavoring properties.8  While 
mixed microbial cultures have the tendency to promote spoilage and undesirable off-
flavors, many successful processes have been developed using bacterial monoculture and 
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purified enzymes.9  Compounds such as vanillin8-10, γ-decalactone (peach)8, and 
raspberry ketone9 are all accessible via biocatalytic routes.  A major continuing challenge 
in the use of biocatalysis for the production of natural products is the time and effort 
necessary for the discovery of natural pathways of production and the recombinant 
production of the enzymes involved.8, 9  Future possibilities for growth in this industry 
involve the discovery of novel flavor compounds by the biocatalytic generation of 
combinatioral libraries of functionalized natural products.11   
2.1.4.4 Enzymes in the Cosmetic Industry 
Biocatalysts are also being employed in the cosmetic industry in the synthesis of 
emollients, emulsifiers, and thickening agents.  Here, the main advantage is that the use 
of enzymes can vastly reduce the number of steps required to make the product.  In 
addition, minimizing the use of organic solvents is desirable because residual solvent 
causes an undesired skin drying effect.  The main disadvantage to enzymatic routes is 
their cost effectiveness; although this can be improved via catalyst recycle.  One example 
of a competitive process is the production of cetyl ricinoleate via esterification of cetyl 
alcohol with ricinolic acid using an immobilized lipase as the catalys.12  
2.1.4.5 Enzymes in the Pharmaceutical and Fine Chemical Industries 
Enzymes have found extensive use in the chemical industry.  For example, there 
are numerous processes in pharmaceutical and fine chemical industries that utilize 
biocatalysts.  The compounds used in these industries must be of high regio- and optical 
purity, thus the high selectivity of biocatalysts is their main advantage.  A wide range of 
biocatalysts are employed for both direct synthesis and the resolution of racemic 
mixtures.10, 13-16  Examples of industrially viable processes using biocatalysts include the 
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production of α- and β- amino acids, enantiomerically pure amines and alcohols, 
regioselective reactions involving carbohydrates, and many highly complex 
pharmaceutical intermediates.   
Biocatalytic process development in the pharmaceutical industry faces particular 
challenges with regard to throughput and downstream processing, based on the particular 
phase of trial that the compound is currently in.  In early phases, such as compound 
discovery and lead optimization, synthesizing the compound quickly is the most 
important factor, and the process productivity and cost are largely ignored.  It is also 
important, in the early stages, to be able to synthesize both enantiomers of chiral 
molecules to test their effects independently.  As the drug molecule moves closer to the 
market, emphasis shifts to developing a scalable, cost-effective process.  Downstream 
processing issues become important, particularly in determining the competitiveness of 
the biocatalytic process compared to alternate chemical synthesis routes because the cost 
and ease of separation impact the overall economic viability of the synthetic route 
ultimately chosen.17   
With regard to throughput, to be competitive a process utilizing a biocatalyst must 
have a high volumetric productivity.  Therefore, the enzyme must be highly active and 
not subject to substrate inhibition at high concentrations of reactant.17, 18  The ability to 
react with less expensive starting materials is also desired.17 
The main challenge in the downstream processing of products of enzymatic 
reactions is the difficulty with extractive recovery of the products.  When organic 
products are being extracted from a mostly aqueous reaction medium into an organic 
layer, the whole cells or isolated enzymes tend to aggregate into an emulsion which is not 
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easily broken.  Some processes use the addition of de-emulsifying agents, adsorption, or 
other techniques to circumvent this problem; however, there are many instances where 
this tendency to emulsify will render a process infeasible.  The ability to use immobilized 
enzymes or whole cells has some benefit in this instance as filtration can be used to 
recover the catalyst pellets.17    
Further challenges will emerge as renewable feedstocks (e.g corn stover) are used 
as precursors for synthesis.  Most research is conducted on clean samples and assumes 
idealized kinetics.  In reality, many of these crude substrates are complex mixtures 
containing inhibitors which impede the desired reaction, but allow side reactions to 
continue.19   
In particular, the high degree of complexity of pharmaceuticals with a large 
number of functional groups and chiral centers requires catalysts that can be highly 
selective without the need of protection and deprotection steps that add to cost and waste 
generation.13  Biocatalysts offer an advantage in the case of highly complex syntheses.  
Here, it is desirable to reduce number of steps to product formation, replace difficult steps 
with more simple ones, improve optical purity, to improve reaction conditions to 
eliminate potentially unsafe steps, and to reduce waste.20  An example is the production 
of penicillin-derived antibiotics by various β-lactam acylases.21  In this case, the complex 
antibiotic structure is created in two steps.  First, the component 6-aminopenicillanic acid 
is obtained via fermentation and the enzymatic hydrolysis of penicllin G.  This core 
structure is then reacted with a side chain compound, which is added via acylation.  The 
chemical synthesis of penicillin-like structures is far more complex, with higher energy 
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consumption (taking place at -40 °C) and generating much more waste.22 Thus, the 
biocatalytic method has gained favor. 
2.1.4.6 Enzymes in Commodity Scale Processes 
The use of biocatalysts in the chemical industry is not limited to the 
pharmaceutical and fine chemical industries, but has also been used on the bulk chemical 
scale.  For instance, high fructose corn syrup, a sweetener present in sodas and many 
other products is produced by the enzymatic hydrolysis of starch followed by the 
isomerization of glucose to fructose by using another enzyme, glucose isomerase.  More 
than one million tons of high fructose corn syrup are produced annually by this 
biocatalytic process.23  In addition, acrylamide, the monomer unit of a mass produced, 
large volume, commodity polymer is produced on the 11 million ton scale using the 
nitrilases from various Rhodococcus species.24 
2.1.4.7 Enzymes in the Petroleum Industry 
One industry which may benefit from the implementation of biocatalysis in the future 
is the petroleum industry.  In the past, the main focus was on microbiologically enhanced 
oil recovery, treatment of waste streams, and bioremediation of contaminated soils.  
However, new research toward the biologically-based desulfurization, denitrogenation, 
and demetallation of fuels and the lightening of crude oil via whole cell biocatalysts is 
increasing.  The main challenge facing the implementation of biocatalysts for these 
purposes is the enhancement of their activity and stability in the highly hydrophobic, 




2.2  Changing the Paradigm of Biocatalyst Process Development 
Current methods of process development for biocatalysts usually attempt to 
circumvent the weaknesses of the biocatalyst by changing the process conditions.  For 
example, if the reactants are sparingly soluble in water, but the enzyme is not tolerant to 
high levels of organic solvents, the reactor volume will be increased.  This results in a 
compromised process with low volumetric productivity which is usually not 
economically viable.  A better solution would be to determine the optimal processing 
parameters based on the particular constraints of the reaction.  Here, the solubility of the 
reactants and products must be considered in choosing a reaction medium: their stability 
with respect to temperature and pH will, in part, dictate process operating conditions; and 
the equilibrium of the underlying reaction may suggest an operating temperature.  
Additionally, the type of reactor must be considered.  If an immobilized catalyst is used, 
there may be diffusion effects.  If a plug flow reactor is packed with catalyst beads, there 
might be concentration gradients—therefore a catalyst with a lack of substrate and 
product inhibition and a low Km (substrate concentration to obtain a rate one-half of the 
maximum) is preferred.  Once these parameters are set, a biocatalyst can be engineered to 
work within them.  The shift from changing the process to suit the catalyst to improving 
the catalyst to work in the best process represents a new paradigm in biocatalyst 






As discussed above, the current challenges facing the widespread adoption of 
biocatalytic processes center on their instability in certain situations, namely at high 
temperature and in the presence of organic solvents.  Additionally, there is not an existing 
biocatalyst for every desired reaction.4  Both of these problems can be alleviated by 
improving the stability or changing the substrate specificity of the biocatalyst via protein 
engineering (for examples, see 5, 26-29). 
2.3 Protein Engineering 
2.3.1 Protein Engineering Definition 
Protein engineering is the creation of new or improved enzymes or proteins by 
altering an enzyme or a protein with inadequate properties.  Many specific methods for 
protein engineering exist, but they can be grouped into two major categories:  those 
involving rational design of protein changes and combinatorial methods which make 
changes in a more random fashion. 
 
Figure 2.1:  A comparison of conventional biocatalyst process development and 
the ideal development.1 
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2.3.1.1 Rational Methods of Protein Engineering 
Rational methods of protein engineering involve the selection of particular amino 
acid residue to target for alteration to achieve the desired outcome based on initial 
knowledge of the protein structure, function, and chemical mechanism.  Usually, a 
limited number of variants are explored and the residues that are targeted are often those 
involved in contact with the substrate.  Changes can be made via site-directed 
mutagenesis, in which the investigator selects both which amino acids to change, and 
what specific changes should be made.30  A related method is site-saturation mutagenesis, 
where specific amino acid residues are targeted, but all 20 amino acids are tried at each 
location.31  More recently, the complete de novo design of protein backbones based on 
the combination of various optimization algorithms with protein predictive force fields 
has been applied,32 though this field is still in its infancy.  As more knowledge is gained 
as to how the protein structure affects its function, rational design of proteins with 
particular functions will become easier to perform.    
2.3.1.2 Combinatorial Methods of Protein Engineering 
 Combinatorial methods of protein engineering can be further subdivided into 
methods that generate point mutations, insertions, or deletions and methods involving 
recombination of one or more parental genes.  The former includes error-prone 
polymerase chain reaction (PCR), a process by which errors are introduced into the 
growing DNA chain during normal replication.  This can be accomplished by exploiting 
the natural errors produced by Taq DNA polymerase in the presence of manganese and 
unbalanced concentrations of dNTPs, using a polymerase which has been modified to 
increase its error rate (such as Mutazyme® from Stratagene), or by including a universal 
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base such as inosine that hydrogen bonds with any of the normal nucleotides.33, 34  
Another method for introducing random errors into the gene is the use of a mutator strain 
of E. coli in the transformation step, which has been engineered for decreased fidelity of 
replication.35 
 There are a very large number of recombination protocols available in the 
literature.  Some, such as DNA shuffling and RACHITT (Random Chimeragenesis on 
Transient Templates), rely on annealing of mixed DNA fragments from different parents 
followed by replication of the newly constructed chimeras.  Others, like the Staggered 
Extension Process (StEP) and RDA-PCR (Recombination-Dependent Exponential 
Amplification Polymerase Chain Reaction) are based on PCR with short extension time 
and template switching between parents to create diversity.33-35  Both the annealing and 
PCR- based methods require a certain degree of sequence homology for recombination to 
take place.35  For a third group of methods, including ITCHY (incremental truncation for 
the creation of hybrid enzymes) and sequence-independent site-directed chimeragenesis 
(SISC), this is not a requirement.  These methods rely on the directing of crossovers via 
ligation-mediated assembly, and thus are not bounded by the homology of the sequence 
in question.  One drawback, however, is that the number of crossovers obtained via these 
methods is limited.33, 34 
2.3.2 Screening and Selection to Identify Improved Mutants 
Following diversity generation, each member of the library must be evaluated to 
determine whether it has the properties of interest.  There are two main ways of achieving 
this, tying the survival of the host organism to the function of the protein of interest 
(selection), or individually assaying each protein (screening). 
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2.3.2.1 Advantages and Disadvantages of Selection 
Selection involves transforming the library into the host cell and then plating the 
transformants onto some sort of selective medium which only allows survival of the 
organism if the protein is present.  It is much less time-intensive, allowing for the 
analysis of 109-1011 colonies per round of evolution.  Additionally, selection is very 
sensitive—less than 1% activity over background is required for organism survival.  
However, due to the adaptive nature of the host organism, selection can sometimes result 
in false positives (i.e. the bacterium changes in ways not related to the evolved protein to 
prevent its death) and it merely provides a yes/no answer—catalytic rates must still be 
measured in a separate experiment.  Finally, not all activities of interest can be tied to 
host cell survival.36 
2.3.2.2 Advantages and Disadvantages of Screening 
Screening entails analyzing each colony for its level of the desired reaction.  
Screening involves three steps:  the separation of individual colonies into their own assay 
compartment, the generation of signal (reaction), and the detection of the signal 
(analysis).37  The process is much more resource- and time- intensive, so only about 105-
107 colonies can be screened in each round of evolution.36, 37  The capacity limitation 
means that only a fraction of the generated library is screened in any round, making it 
likely that some highly active mutants may be missed.37   
One problem with current directed evolution experiments is that high throughput 
screening conditions do not mirror the way in which the final enzyme will be used 
industrially because they take place in the growth medium in the presence of cell lysate, 
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rather than with isolated enzyme which may be immobilized and will be subject to 
recycle.3 
2.4 Summary 
In summary, biocatalysis is gaining favor in a variety of industries due to its 
selective nature and the potential for more environmentally favorable processing 
conditions.  The main challenge to developing economically viable biocatalytic processes 
is the lack of stability of these catalysts to many conditions such as the presence of 
organic solvents or extremes of temperature, which are often necessary for large-scale 
production.  Protein engineering is a valuable tool to improve these properties, and 
therefore the usefulness of biocatalysts.  In the future, the tailoring of biocatalyst 
properties to the process at hand (rather than the reverse) will make biocatalytic processes 
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CONSTRUCTION AND EXPERIMENTAL VALIDATION OF A MONTE-




Pooling is the simultaneous analysis of multiple samples followed by the 
deconvolution of pools that show promising results.  Similar techniques have been used 
to increase throughput in combinatorial chemistry for drug discovery,2, 3 genome 
sequencing and chromosome mapping,4-7 oligonucleotide microarrays,8, 9 and in testing of 
biological samples such as blood for the presence of organisms, contaminants, or 
characteristics of interest.10-13  As noted by Bruno et. al., “Whenever the objective is to 
find ‘needles in a haystack’ a reliable test indicating whether at least one needle occurs in 
a specific part of the haystack can greatly facilitate the isolation of the needles“.6  In each 
case, the object is to balance the increase in sample size obtained by pooling with the 
decrease in ability to detect the analyte of interest.  If pools become too large, the signal 




As discussed in Chapter II, directed evolution is an iterative method of protein 
engineering where one or more genes that code for the protein of interest are subjected to 
random mutagenesis or recombination.14, 15  The resulting variants, or mutant proteins, 
must then be sorted into good and bad performers.  If the activity of interest cannot be 
tied to host survival (selection), then each mutant must be assayed individually, a process 
called screening.  Because of the time- and resource- intensive nature of screening, 
laboratories are typically limited to screening 105 to 107 mutants per round of directed 
evolution.16  This capacity limit impacts the way error-prone PCR experiments are 
conducted:  since higher mutation frequencies yield larger numbers of inactive mutants, 
experimenters typically do not generate more than 1-2 mutations per gene.  This ensures 
that the majority of mutants that are screened have at least some activity.1  While this 
policy means that most of the screened library will be active, it decreases the accessible 
portion of sequence space.  Therefore, if large improvements in the protein of interest 
Figure 3.1:  Finding the optimal level of pooling 
 25
require many mutations, the probability that this solution will be tested is very low.  
Additionally, when recombination methods are used to generate diversity, the proteins 
that are actually assayed represent a very small portion of the ones that are produced.  
Therefore, it is likely that many improved proteins are missed due to the limitations of 
assay throughput.    
We propose to extend the concept of pooling to the directed evolution of proteins.  
However, the level of pooling which can be tolerated in any system will depend on 
several factors, such as the background level of activity that the parental strain possesses, 
the accuracy level of the assay in question, how frequently improved mutants are 
produced, and what level of improvement is achieved by these mutants.  The optimal 
level of pooling will vary with the particular situation at hand; therefore it would be 
useful to have a simulation model to test different conditions in silico before planning 
experiments.    
The initial validation of the proposed model required a highly controlled 
experimental system with a colorimetric reporter assay.  A first level test system was 
comprised of two enzymes, β-galactosidase (LacZ) and β-glucuronidase (Gus), which are 
thought to be evolutionarily related glycosyl hydrolases (Figure 3.2).17, 18  β-
glucuronidase does catalyze the hydrolysis of the substrate of β-galactosidase, but at an 
approximately 106-fold lower level.  A mixture of LacZ and Gus thus comprises a binary 
system for which direct calculations of the probability of finding an improved enzyme 
can be made, providing further corroboration of the accuracy of the model.  In addition, 
directed evolution experiments to increase this activity have been conducted,19-21 yielding 
mutants of various levels of galactosidase activity with which we could test more 
 26
complex activity distributions.  Additionally, several reporter compounds are available to 
detect galactosidase activity; most of these allow for visual detection of the presence of a 
supermutant.  Thus, these enzymes and their mutants comprise a system that can be used 





3.2 Materials and Methods 
3.2.1 Computer Simulations 
The pooling experiments are complex enough that an analytical probability model of 
the system is unlikely to yield tractable closed-form results when considering complex 
assay accuracies or distributions of underlying population activity. This led to the 
development of a stochastic simulation model using Monte-Carlo methods.22, 23 The 
simulation essentially maps an idealized experimental procedure into an executable 
algorithm (see Figure 3.3).  Monte-Carlo sampling is required whenever there is an 
underlying non-deterministic choice to be made.  The Jet Random Number Generator 
from the European Center for Nuclear Research (CERN24) was used to create random  
Figure 3.2:  The substrates of β-galactosidase and β-





numbers from different probability distributions.  Sampling is required during the 
following points in the simulation: 
1. The pipetting of cells is assumed to draw a certain quantity of liquid whose 
volume is significantly greater than the volume of the cells that is expected to be 
within it.  Thus the probability that any subvolume contains a cell is thus very 
small, a rare event, and the number of subvolumes very large.  This enables the 
use of the Poisson distribution to represent a single pipette action.  The mean of 
the Poisson distribution is taken to be the intended target number of cells per well. 
The concentration of the cells and the quantity of the original mixture are 
considered to be uniform and significantly greater than the amount that is being 
pipetted, so the overall process is represented by a series of identical, 
independently distributed trials.  For example, if one cell per well is the target, 
then the probability of a given cell being empty is equal to 1/e, or 0.368. 
2. The activity curve for a population of cells is obtained by plotting the catalytic 
activity against the corresponding number of cells. A directed evolution 
experiment would sample for this activity curve by creating variants. The 
probability of a cell having an activity within a given range is dependent on the 
underlying population and processes that have been used to select it.  For the 
Figure 3.3:  Pooling simulation model flowsheet 
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purposes of early model validation, cells with only two different levels of activity 
form the population. Thus, the activity curve was assumed to be a discrete 
probability distribution, with two masses, the probability of a supermutant and the 
probability of the dud, summing to unity.  Although the activities of the 
supermutant and dud are assumed to be fixed, it is actually an average activity of 
the population and a finite spread would occur around it. However, it was 
unnecessary to represent this finite spread because it was assumed that it could be 
reflected in the assay accuracy.  In later simulations, a more complex activity 
curve involving several mutants of varying activity levels was input.  In practice, 
the model can handle any type of activity curve. 
3. A normal distribution is used to model the assay error; however, in simulation 
runs involving a large activity level difference, the accuracy was sufficiently high 
that there was little chance that the two cell types could be confused because of 
assay error.   
The computer code was constructed to allow for tracking of the true identity of cells 
in each well at the end of the simulation, allowing the identification of false positives. 
3.2.2 Simulation Software 
 The simulation code (Appendix 1) is implemented in Java for ease-of-use, 
portability, and extensibility.  The object-oriented nature of Java is a perfect fit for the 
experiments because each physical part of the process is described by a class.  These 
classes can be individually tested and are easy to replace if the model needs to be 
changed.  Once the code is compiled, it can be used on any platform that supports a Java 
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Virtual Machine, eliminating the need to implement different versions for different 
operating systems and making distribution simple.   
 The large scale of data being processed requires a fast computer with significant 
storage capability.  A typical experiment has 80 well plates with 384 wells each, and each 
well with 1-100 cells.  Each of those 1-2 million cells has data that needs to be stored, 
manipulated, and compared for each round of directed evolution.  The running time for 
simulations on a Pentium 4 2.4 GHz processor with 512 Mb of RAM is on the order of a 
few minutes, depending on the number of cells sampled per well. 
3.2.3 Verification of Simulation Results through Analytical Probabilistic Model 
 For the simulations involving a binary activity distribution, the modeling of the 
experimental results can also be approached through an analytical probabilistic model 
that captures the basic features of the pooling procedure.  It is important to note that the 
assay accuracy also cannot be accounted for in the calculations, thus this calculation 
could only be made for the binary system involving the wild-type LacZ versus the wild-
type Gus (AR=38,000). This model was used as further corroboration of the simulation 
procedure.  
 The number of cells sampled from the initial pool is assumed to follow a Poisson 
distribution, for the same reason as its use in the simulation. For an average j cells/well, 
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Assuming that the initial pool of cells is infinite in number and the cells taken out in 
samples do not affect the supermutant:dud ratio (SR), the probability of picking out i 
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where fD is the fraction of duds in the initial pool. Thus, the probability of sampling only 
duds or no cells when the number of cells sampled is given by a Poisson distribution with 
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where n is a number much larger than the average cells per well j such that the term 
Pi,j(fD)i is negligible. The probability of sampling one or more supermutants in a well can 
now be written as: 
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The probability of finding k wells with one or more supermutants when sampling a total 
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Note that the assay accuracy is assumed to be 100% in this derivation. From Eq. (5) the 
average number of supermutant cells detected for a dud ratio of fD in the pool when 
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3.2.4 Materials 
ImmunopureTM o-nitrophenylgalactopyranoside was obtained from Pierce Biotechnology 
(Rockford, IL).  All other chemicals were obtained from Sigma Aldrich (St. Louis, MO).  
Molecular biology reagents and LB medium were purchased through VWR International 
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(Suwanee, GA).  The genetic constructs for the wild-type β-galactosidase and β-
glucuronidase were a kind gift of Dr. Ichiro Matsumura (Emory University). 
3.2.5 Co-culturing Experiments 
 It was essential to determine whether cells expressing β-galactosidase and β-
glucuronidase grow at the same rate, because if they do not the pooling ratio set at the 
beginning of the experiment would not be retained at the time of the assay.  Therefore, 
cells expressing β-galactosidase and β-glucuronidase were grown separately in glass 
culture tubes at 37°C with 250 rpm shaking, and in a 1:1 co-culture under the same 
conditions, and growth curves based on optical density readings at 600 nm were 
constructed to compare the behavior of the mono- and co- cultures.   
3.2.6 Cell Growth and Assay Conditions 
Screening was conducted using cells expressing β-galactosidase as the 
supermutant and cells expressing β-glucuronidase as the dud.  Genetic constructs for each 
enzyme are described in detail elsewhere.19, 25  Briefly, the gene encoding for each 
enzyme was cloned from E. coli genomic DNA into a library of pET20b vectors in which 
the T7 promoter has been removed and the lac promoter randomized to produce varying 
levels of constitutive expression,26 transformed into E. coli INVαF’(lacZ∆M15) cells and 
selected for the optimal and most stable level of expression.   
Screening assay procedures were derived from Geddie et. al.27  Initial stocks of 
each cell type were created by growing a single colony in Luria-Bertani (LB) medium 
supplemented with 100 µg/mL of ampicillin to mid-log phase, diluting 50:50 with 33% 
glycerol, aliquotting into microcentrifuge tubes, and snap freezing with liquid nitrogen.  
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One tube of each type was then thawed and titered by serial dilution to determine the 
concentration prior to cell dilution. 
For each screening run the supermutant and dud were mixed in a given ratio, the 
supermutant:dud ration (SR) (1 supermutant per 104, 105, or 106 duds), and then diluted 
to the appropriate number of cells per 5 µl (1, 10, 40, or 100).  Cells were allocated to 80 
384-well plates using a Multidrop 384 (Thermo Labsystems, Waltham MA), sealed with 
silicon mats (Specialty Silicon, Rochester NY), and grown overnight at 37°C in a rotating 
incubator (Environmental Express, Mt. Pleasant SC).  The mats were removed and 50 µl 
of substrate solution (0.5 mM ortho-nitrophenyl-galactopyranoside (oNPG- Figure 3.4) in 
1X Phosphate Buffered Saline, pH 7.3) was added to each well.  The plates were 
incubated at room temperature for 3 hours and visually inspected for the appearance of 
bright yellow color indicating presence of the supermutant.  For tests of assay limitations 
and comparison of assays, forced dilutions of cells expressing the “supermutant” and the 
“dud” (1:10 through 1:105) as well as pure cultures of each type were grown overnight in 
glass culture tubes, 5 µl of these cultures were dispensed into each well of a 384-well 
plate, 50 µl of oNPG substrate solution or 25 µl of 0.1 mM resorufin-β-D-
galactopyranoside (ResGal-Figure 3.4) in 10 mM Tris-HCl pH 7.5 were added, and plates 
were incubated at 30°C.  After 3 hours, the absorbance of the plates incubated with the 
oNPG substrate was read at 405 nm using a Fluorostar Galaxy (BMG Technologies, 
Offenburg, Germany).  Plates used in the resorufin assay were incubated for 1.5 hours 
and assayed in fluorescence mode (excitation wavelength 544 nm, emission wavelength 
590 nm).  Because the use of pooling in a directed evolution experiment would require a 
second stage to isolate the true supermutants that were present in the winning well (two 
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sets of 80 plates would be necessary for a single set of pooled experiments), experiments 
of unpooled conditions were increased to a sample size of 160 plates to keep the 





3.2.7 Cell Dilution Check with Coulter Counter 
 To determine whether the final dilution to the proper number of cells per well was 
accurate, the cell counts in samples of final solution were checked using flow cytometry 
(Multisizer TM 3, Beckman Coulter, Fullerton, CA).  Several routes to the final dilution 
were examined to determine whether there was variation in the final number based on the 
method of dilution. 
3.2.8 Mutant with 15-fold difference in activity level 
The S557P, T509A/S557P, and T509A/S557P/N566S/K568Q mutants 19, 20 were 
created using the QuikChange Site Directed Mutagenesis Kit (Stratagene, La Jolla CA) 
and sequenced to confirm the changes (Perry Mars, Fundamental and Applied Molecular 
Evolution Center, Emory University).  The mutant and wild-type cultures were grown in 
Luria-Bertani medium to saturation in 10 mL cultures and the activity of the mutants, as 
well as the native β-glucuronidase and β-galactosidase, was verified in cell lysate (to 
Figure 3.4:  The substrates ortho-nitrophenylgalactopyranoside (left) and 
resorufin-β-D-galactopyranoside (right)   
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represent pooling conditions) and in purified form following his-tag purification with 
Talon Metal Affinity Resin (BD Biosciences, San Jose CA) using continuous monitoring 
of the change in absorbance at 405 nm.  Forced dilutions to determine the limits of the 
assay were performed as for the wild-type, but incubation times were increased to allow 
for the slower reaction.  Screening runs were conducted with 30 µl of the resorufin 
substrate solution (0.1 mM in 10 mM Tris-HCl pH 7.5) and an incubation time of 9 
hours. 
The assay of pools of T509A/S557P/N566S/K568Q as the supermutant and β-
glucuronidase as the dud (activity ratio, AR=15) were conducted at a SR of 1:104 and 
pooling levels of 1, 5, and 10 cells per well.  Due to the cost of the resorufin substrate, 
sample sizes were limited to 10 plates per experiment.  Growth conditions were as 
described for the β-galactosidase /β-glucuronidase experiments and assay conditions 
were as described for the forced dilution experiments.   
3.2.9 Standard Directed Evolution Activity Curve Experiments 
The T509A/S557P/N566S/K568Q mutant (AR=15), the S557P/T509A mutant 
(AR=2), wild-type β-glucuronidase (AR=1), and cells harboring an empty plasmid 
(AR=0) were mixed in appropriate ratios to reproduce a typical activity curve (Figure 
3.5).  Stage one experiments were conducted as described above for cell dilution 
procedures, using a pooling level of five cells per well and an unpooled control.  After 
assay, the top 15 wells from the pooled experiment were streaked onto LB medium 
containing ampicillin, and grown overnight.  Six of the resulting colonies were chosen for 
each winning well from stage one and picked into 96-well plates for stage two.  As 
additional verification, three samples from each of the top five wells were made from the 
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unpooled plate and picked into 96-well plates.  The stage two colonies were grown 
overnight with agitation to stationary phase, 20 µl of each well was transferred to fresh 




































Figure 3.5:  Standard Activity Distribution from a directed evolution experiment by 
Cirino et al.1 with very few improved mutants, a large plateau of wild-type activity 
level, and about 30% inactives.  Our smoothed approximation consisting of the 
mutants with 15-fold, 2-fold, wild-type, and no activities.  The 15-fold mutant is 
included at a frequency of about 0.25 per 96 
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3.3 Results 
3.3.1 Co-culturing Experiments 
 The results of the co-culturing experiment show that LacZ and Gus suggest that 
LacZ and Gus grow at a similar rate to each other and that the mono-cultures behave 




















3.3.2 Flow Cytometry Check of Dilution 
 Flow cytometry was used to check the dilution procedures.  Figure 3.7 
shows the actual versus expected number of cells obtained via three different dilution 
procedures.  The discrepancy between the predicted concentration of cells per well and 
Figure 3.6:  Results of the co-culturing experiment.  Growth was done at 37°C 
with 250 rpm shaking in LB medium. 
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the counted one differed by only 5-10%.  The agreement was far closer when flow 
cytometry was used as opposed to when spread plates were used to determine cell 
concentration.  Note that Run B has large error bars due to problems with the orifice 































3.3.3 Simulations and Direct Calculations 
Simulations were conducted using activity ratios (AR) of 15, 38000, and 106 and 
supermutant:dud ratios (SR) of 1:104, 1:105, and 1:106  respectively.  At the lowest 
activity ratio (15), pooling conditions beyond 5 cells per well predicted finding 
supermutants in virtually all wells at all supermutant:dud ratios, a result of false positives.  
At activity ratios of 38000 and above, the number of supermutants found increases 
linearly with the number of pooled cells per well, and more supermutants are found as the 
Figure 3.7:   Check of cell dilution procedures with flow cytometry 
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supermutant:dud ratio increases (example: Figure 3.8).  The predicted number of 
supermutants for an activity ratio of 38000 and of 106 is nearly identical, indicating that 
once the activity ratio is far above the threshold of assay detection, the true number of 
supermutants is always detected. Theoretical calculations based on the Poisson 
distribution (see developments above) agree with the simulated results, for the most part 
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Figure 3.8:  Example simulation data.  The number of supermutants 
detected as a function of cells per well is plotted for all activity ratios at 
a supermutant:dud ratio of 1:105.  The data for activity ratio (AR) of 15 
is plotted on a secondary axis to aid in interpretation.    
 39
3.3.4 Initial Experimental Validation 
Initial experiments focused on two populations with a large difference in activity 
level.  The activity ratio of cells expressing β-galactosidase to cells expressing native β-
glucuronidase on oNPG in cell lysate was measured to be 38000; thus, this number was 
used in simulations.  Published estimates of the activity difference range up to 106, but 
these are for pure enzymes and do not represent the screening conditions of a whole-cell 
assay.  Additionally, as mentioned above, simulations do not substantially differ for these 
activity ratios. 
The model was tested at supermutant:dud ratios of 1:104-1:106.  Most experiments 
were conducted at a supermutant:dud ratio of 1:105, because the largest difference in 
detection ability between pooled and unpooled experiments occurs here (central line of 
Figure 3.9).  Additional experiments were conducted at the interesting endpoints of 1:104 
and 1:106 supermutant:dud ratio.  In the former case, the model always predicts that a 
supermutant will be found, even if one does not do pooling.  In the latter, the model 
predicts a very low probability of finding the supermutant, even at pooling levels of 100 
cells per well.  Figure 3.10 shows the comparison of the theoretical calculation, the 
simulation model and the experimental results.  For the supermutant:dud ratio of 1:105, 
the calculations, simulations, and experimental results agree very closely, indicating that 
the model fits well. For the SR of 1:104 and 1:106 the simulated and calculated results are 
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Figure 3.9:  Comparison of simulated and experimental results for pooling with cells 
expressing β-galactosidase as the supermutant and cells expressing β-glucuronidase 
as the dud.  The number of supermutants detected is plotted versus the number of 
cells pooled per well.   
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3.3.5 Forced Dilution Experiments 
Both to test the limits of pooling and to compare two assays of varying accuracy, 
artificial pools of cells expressing β-galactosidase and cells expressing β-glucuronidase 
were tested in the oNPG and resorufin assays.  Figure 3.10 indicates that pools of 1:103 
and higher do not allow for the detection of the supermutant from the background of the 
assay.  This is true even when incubation times are increased (data not shown) and is 
probably a function of the relative rates of hydrolysis of the supermutant and dud.  Since 
our method involves visual inspection, it was also important that we be able to 
distinguish wells containing a supermutant by eye.  This was much easier in the case of 
the resorufin assay where colors ranged from orange (unreacted) to magenta (fully 
reacted), versus in the oNPG assay which calls for distinction between various shades of 
































































Figure 3.10:  Assay of artificial pools of cells expressing β-glucuronidase and 
cells expressing β-galactosidase.  For the oNPG assay 50 µl of 0.5 mM oNPG in 
1X phosphate buffered saline were added to each well and well plates were 
incubated for 4 hours at 30°C before being assayed spectrophotometrically at 405 
nm.  For the ResGal assay 25 ml of 0.1 mM Resorufin-β-D-galactopyranoside in 
10 mM Tris-HCl were added to each well and plates incubated at 30°C for 1.5 
hours.  Fluorescence units were determined using a fluorimeter with excitation at 






3.3.6 Experiments at Lower Activity Level Differences 
Since differences in activity level of 38000-fold are rare for mutants created by 
directed evolution, particularly in initial rounds, pooling experiments with a mutant of β-
glucuronidase (T509A/S557P/N566S/K568Q) with 15-fold activity level difference in 
cell lysate were conducted 19, 20.   
Pools of this mutant with cells expressing wild-type β-glucuronidase were tested 
with both assays to determine the limits of pooling for spectrophotometric and visual 
detection.  For the oNPG assay, even pools of 1 mutant: 2 wild-type were barely 
distinguishable spectrophotometrically from the wild-type background (Figure 3.12).  
However, for the resorufin assay, ratios of up to 1 mutant: 10 wild-type were 
distinguishable both with the fluorimeter (Figure 3.12) and visually (data not shown).  
Figure 3.11:  Full color photos of the assay results for cells expressing β-
galactosidase (left) and cells expressing β-glucuronidase (right).  The top plates 
are the resorufin assay, the bottom are the oNPG assay 
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Two additional mutants created in the process of making the quadruple mutant, S557P 
and T509A/S557P, both with approximately two-fold increased specific activity over the 
wild-type GUS were also assayed to determine whether they could be detected in pools.  
Neither of the mutants was distinguishable from wild-type GUS in either assay (Figure 
3.12).  Simulations results incorporating the coefficient of variation of both assays agree 
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Figure 3.12:  Assay of forced pools of cells expressing β-glucuronidase with cells 
expressing the 3 mutants:  S557P, T509AS557P, and T509A/S557P/N566S/K568Q.  The 
S557P and T509AS557P mutants have 2-fold increased specific activity over wild-type 
GUS in cell lysate assays, while the T509A/S557P/N566S/K568Q mutant has 15-fold 
increased specific activity in cell lysate assays.  The oNPG assay was conducted as for 
the β-galactosidase and β-glucuronidase case, but incubation time was increased to 6 
hours.  The resorufin assay was conducted as for the β-galactosidase and β-glucuronidase 
case, but incubation time was increased to 9 hours (secondary axis). 
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To test the validity of the model at low activity ratios, experiments using the 
resorufin assay, a supermutant:dud ratio of 1:104, and pools of 1, 5, and 10 cells per well 
were conducted with the quadruple mutant.  Figure 3.13 compares the simulation and 
experimental results for these experiments.  At an activity ratio of 15, there are a 
substantial number of false positives occurring in the simulation, particularly at and 
above 10 cells per well (axis has been truncated).  Once these are taken into account, the 
model predicts the number of supermutants detected fairly well.  When an activity ratio 
of 35 (green line) is used to run the simulation, there are negligible numbers of false 
positives.  Note that this simulation predicts the same number of supermutants as the 
previous simulation when the false positives are subtracted.  Other supermutant:dud 
ratios were not tested because too few supermutants were expected in the small sample 
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3.3.7 Standard Activity Distribution 
Figure 3.14 compares the number of T509A/S557P/N566S/K568Q (AR=15) 
mutants predicted to be present by the simulation with the number experimentally 
detected for pooled and unpooled conditions after the second stage.  The simulation 
accurately predicts the number detected regardless of the assay employed.  This result 
may seem to be in contrast with the forced dilution experiments, however the presence of 
the inactive mutant means that the T509A/S557P/N566S/K568Q (AR=15) mutant can be 
detected with some probability (when these end up in the same well). 
 
Figure 3.13:  Comparison of simulation and experimental data for pooling with cells 
expressing β-glucuronidase and cells expressing the mutant with 15-35-fold 
increased activity level (T509A/S557P/N566S/K568Q).  Experiments were 










0 1 2 3 4 5





















3.4.1 Simulation Results 
The simulation results reflect the physical phenomena that the experimenter 
witnesses.  For instance, when the activity level difference between the supermutant and 
dud is much larger than the assay accuracy, the simulation always detects the true number 
of supermutants present.  Hence, the simulated numbers of supermutants for the activity 
level ratio of 38000 and 106 are almost identical.  Additionally, simulations at low 
activity ratio (e.g. 15) and high pooling level predict the occurrence of a supermutant in 
Figure 3.14:  Predicted and actual number of AR=15 mutant detected when 
pooling with a more typical activity distribution 1.  Experiments were conducted 
using one 96-well plate for each stage. 
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every well.  The physical manifestation of this result would be the inability to distinguish 
between any of the wells because the pooling level is too high to allow for the detection 
of the supermutant within the error of the assay.  The simulation procedure allowed us to 
record which “supermutants” were false positives and which were false negatives.  At 
low activity ratios, a substantial number of false positives were detected as evidenced by 
Figure 3.14.  The numbers of false positives were negligible at higher activity ratios, 
when the difference between improved and unimproved mutants is far larger than the 
assay error in detection.  The number of false negatives was insignificant in all cases.  
3.4.2 Model Validation 
Overall, the experiments support that the model accurately predicts the number of 
supermutants that will be found for many cases.  Among the variables accounted for in 
the Monte-Carlo model, the supermutant:dud ratio has the largest impact on the number 
of supermutants detected.  This is logical, because the more supermutants produced in the 
diversity generation step of directed evolution, the higher the probability that one will be 
sampled for assay.  In our experiments, when one supermutant was generated for every 
104 duds, supermutants were detected even in the unpooled conditions.  On the other 
hand, when one supermutant was generated for every 106 duds, even pooling 100 cells 
per well does not guarantee the detection of a supermutant in every experiment.  The 
results indicate that the amount of diversity generated will greatly impact the success of 
the screening and there is a minimum number of supermutants that must be generated 
before screening is even worthwhile.  Note that although supermutants are found in the 
1:104 SR condition when pooling is not employed, the number of supermutants detected 
still increases when pooling is used.  In an actual directed evolution experiment where 
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there is not a single type of improved variant generated, it would still be beneficial to use 
pooling to bias the populations in future rounds towards higher activity mutants. 
3.4.3 The Utility of Pooling in Directed Evolution Experiments 
Pooling is most suited to cases where an investigator is looking for a large 
increase in activity over the background level, such as the case where one is attempting to 
evolve a new function in a protein.  In this case, the number of mutants with the desired 
activity will be very few; therefore, pooling will be very useful in finding these few 
winners among the vast number with no activity.  In addition, the wild-type parental gene 
is unlikely to have a high level of new desired activity in such an evolution experiment.   
Thus, the noise in the assay is minimized, increasing the number of cells that can be 
pooled before the background overwhelms the ability to detect.  Preliminary evidence of 
this can be seen in the experiments approximating a standard activity distribution.  Here, 
despite what would have been predicted from the forced dilution experiments, we were 
able to find the 15-fold more active mutant with both assays as predicted by the model.  
Further, we expect that the use of pooling will allow for a higher mutation load in error-
prone PCR experiments, as more samples can be screened and high numbers of inactive 
mutants are actually beneficial, as they will not contribute to the background of the assay. 
To use the model to guide directed evolution experiments, an investigator can 
input the assay accuracy, an estimate of the supermutant:dud ratio, and the desired 
activity increase that they wish to detect.  The model will output the proper level of 
pooling to be used.  In practice, the assay accuracy is most easily represented by the 
coefficient of variation seen when replicates are assayed.  The supermutant:dud ratio can 
be estimated from initial library generation experiments, or alternatively, can be varied 
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among likely values to determine the effect on the model.  The desired activity level 
increase can also be varied, but our simulation results show that as long as the activity 
level increase is larger than the assay error, the supermutant will always be detected when 
present.  
3.5 Summary and Conclusions 
In summary, pooling is a method to increase the capacity of high-throughput 
screening assays.  The Monte-Carlo simulation model we have developed and validated 
can be used to predict the expected number of winners in directed evolution experiments, 
given a putative distribution of activity over the population  (for further discussion of the 
activity distribution of actual directed evolution experiments, please see Chapter IV).  
This allows researchers to test several different scenarios before beginning 
experimentation.  Additionally, the end user can input his/her plate capacity, the number 
of wells in each plate, an estimated frequency that good mutants will be created, an 
estimation of the accuracy of the assay, and the activity level increase that he/she hopes 
to find and use the model to determine the number of cells that should be pooled into 
each well for that experiment.  The use of pooling will greatly increase the capacity of a 
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In Chapter III, we introduced the concept of pooling, an established method to 
increase the throughput in screening assays for lead optimization in combinatorial 
chemistry1-3 and in other disciplines (e.g. epidemiology, genomic mapping) where the 
object of an assay is to determine whether a certain agent or sequence is present in a 
group or not.4-7  Screening of combinatorial libraries from protein evolution experiments 
shares the same ‘needle in a haystack’ situation, however, there are several factors which 
complicate the ability to apply pooling to protein engineering.  Thus, we created and 
experimentally validated a Monte Carlo simulation model of pooling on a very controlled 
system created by mixing known entities in various ratios (see Chapter III for details).  
Using this controlled system, we were able to show that pooling increases the assay 
throughput and can be used to increase the number of high activity variants identified in 
the screening step.8  In this chapter, we show that the concept of pooling can be extended 
to a real directed evolution library created in the course of evolution of β-galactosidase to 
β-fucosidase.9  We also extend the system to evolutionary projects involving induction of 
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protein expression, a situation that is very common in the high throughput screening of 
combinatorial libraries.  
4.2 Materials and Methods 
4.2.1 Materials 
Molecular biology reagents and microbial medium supplies were purchased 
through VWR International (Suwanee, GA).  The substrate p-nitrophenyl-fucopyranoside 
was purchased from Sigma Chemicals (St Louis, MO).  The QiaSpin Miniprep kit was 
obtained from Qiagen (Valencia, CA).  The randomized β-galactosidase library was a 
kind gift of Dr. Ichiro Matsumura (Emory University).   
4.2.2 Simulation Model 
The simulation procedures were conducted as described in Chapter III.  The 
model can be set to provide one of three types of output.  SUPERMUTANT allows for 
the evaluation of the number of highest activity mutants detected in the pooling scenario, 
as well as an estimation of the number of false positives in that total.  TOP_PCT outputs 
the level of activity of each of the top X percent of wells specified by the user (the 
PRINT_ALL function can be used to output the exact values of each of the wells).  
Finally, the GREATER_THAN function can be used to obtain a count of all mutants with 
activity greater than the specific ratio, with annotation of the number of false positives.  
In all cases, a false positive occurs when a well is marked as having a supermutant within 
it, but really does not.  A false negative occurs when a well containing a supermutant is 
not marked as such.  Quantification of false positives and negatives can be done in the 
simulation since the true identity of every cell is known.   
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To solve for the number of supermutants that were detected in each case, the 
model requires an input of the expected frequency of occurrence of the improved mutant 
(supermutant to dud ratio), the improvement in activity level compared to wild-type 
(activity ratio), an activity distribution, an assay accuracy, the number of plates in each 
stage, and the pooling level of each experiment.   
4.2.3 Experimental System 
A 1997 paper by Zhang et al showed β-galactosidase, an enzyme that hydrolyzes 
the sugar moiety galactoside from a substrate, could be evolved to increased activity on a 
related sugar, fucoside, by successive rounds of DNA shuffling and screening with 
colorimetric substrates.10  Subsequent work by Parikh and Matsumura showed that 
greater gains in activity and selectivity could be achieved by randomization of three 
active site residues, D201, H540, and N604, which were identified using a semi-rational 
strategy.9  The best mutant obtained in this study was D201/H540V/N604T which is 
identified as the supermutant of interest in our study. 
4.2.4 Model Inputs 
The supermutant:dud ratio, in our case the frequency of occurrence of the 
D201D/H540V/N604T mutant, was estimated from the probability of obtaining these 
codons at each of the three positions based on the codon randomization scheme 
(2/32*2/32*3/32=1/8192).  The activity ratio of the D201D/H540V/N604T mutant to the 
wild-type was determined using whole cells expressing both enzymes.  The activity 
distribution was obtained from a preliminary screen of a single 384-well plate (Figure 
4.1).  Each value obtained was normalized by the average value of the wild-type β-
galactosidase obtained in a parallel experiment, so that data could be input in the form of 
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an activity ratio.  The coefficient of variation of the p-nitrophenyl assay was measured in 
duplicate experiments both on cells grown and induced directly in the 384-well plate and 
on cells grown and induced separately and added to the 384-well plate just prior to 
addition of substrate.  The former was used to estimate the assay accuracy under the 
conditions of the screen, while the latter was used to estimate the assay accuracy in the 
absence of the variability caused by induction.  Parikh and Matsumura screen 10,000 
colonies using a filter lift assay,9 therefore, we screened approximately the same number 
of colonies in 384-well plates without pooling as a basis for comparison (26 plates).   For 
pooled conditions, the same number of plates was used over the two stages for 
consistency, giving a total of 13 plates per stage.  The optimal pooling level was 
determined by running simulations at increasing numbers of cells per well until the 
number of false positives detected was more than the true number of supermutants 





























Figure 4.1:  The activity curve derived from a single 384-well plate screen of the library 
using a substrate solution consisting of 0.5 mM p-nitrophenyl-β-D-fucopyranoside in 10 
mM Tris-HCl pH 7.6.  The absorbance at 405 nm was taken after 2 hours of incubation at 
30 °C.  Absorbance values were divided by the average value of absorbance for a plate 
consisting entirely of the wild-type β-galactosidase assayed in the same manner.  
 
4.2.5 Model Sensitivity Analysis 
Because the activity distribution was estimated from a very small sample of the 
actual library, a sensitivity analysis was conducted to determine the effects of errors in 
the activity distribution.  Various activity curves with the same mean, but different shapes 
were used as input, with all other parameters being held constant and the number of 
supermutants detected in each case was compared.  Additional simulations were 
conducted at varying assay accuracies (coefficient of variation 5%-50%) and varying 
activity ratios (5, 50, 500, and 5000), to understand the interdependence of the activity 




4.2.6 Library Construction Methods 
The library construction procedures have been described elsewhere.9  Briefly, 
three active site residues where chosen for site-saturation mutagenesis based on the 
crystal structure of the E537Q mutant of β-galactosidase with p-nitrophenyl-galactoside.  
Primers were designed based on an NNK scheme (32 possibilities for each residue, all 20 
amino acids, but only one stop codon) with an additional pair used for vector 
amplification.  Whole plasmids containing the library of genes were assembled from 
overlap extension PCR of the four segments, followed by intramolecular ligation.  
Plasmids were transformed into E. coli DH5α∆lac cells by electroporation.  Following 
electroporation, cells were grown for 1 hour at 37°C in 1 mL of SOC medium to allow 
for recovery and then mixed with an equal volume of 33% glycerol and snap frozen using 
liquid nitrogen.  One aliquot was thawed and titered by serial dilution for an approximate 
concentration of successful transformants.  
4.2.7 Cell Growth, Induction, and Assay Procedures 
Frozen aliquots of transformation mixture were thawed on ice and diluted to the 
appropriate number of cells per 5 µl of LB medium supplemented with 30 µg/mL of 
kanamycin (volume of one well) and aliquotted to the wells of ten 384-well plates using a 
Multidrop 384 dispenser (Thermo Labsystems, Waltham MA).  The plates were sealed 
with silicon mats (Specialty Silicon, Rochester NY), and grown for 17 hours at 37° C 
with shaking at 140 rpm.  Subsequently, a single drop of overnight culture was used to 
inoculate 5 µl of fresh LB-kanamycin in a new 384-well plate using a multi-blot 
replicator (V&P Scientific, Inc, San Diego, CA).  Cells were grown for an additional 3 
hours at 37°C with shaking to allow for recovery and 5µL of LB-kanamycin plus 0.2 mM 
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IPTG were added to induce protein expression.  After 1 hour of induction, 50 µL of 
substrate solution (0.5 mM p-nitrophenyl-fucopyranoside in 10 mM Tris-HCl pH 7.6) 
was added.   
The level of substrate hydrolysis was assayed after 4 hours of incubation at 30°C 
using a Fluorostar Galaxy (BMG Technologies, Offenburg, Germany) and a wavelength 
of 405 nm.   
4.2.8 Deconvolution of Winning Pools 
 Wells which turned visibly yellow were picked for deconvolution.  Ten µl of the 
well was inoculated into 5 mL of LB plus kanamycin (30 µg/mL) and grown at 37°C 
with shaking for 6 hours.  These were mixed 50:50 with 33% glycerol and snap frozen.  
One aliquot of each well was thawed, diluted, and spread on LB-kanamycin agar plates.  
Twenty colonies were randomly picked (2-fold oversampling) and subjected to a 
secondary assay to identify the good variants.  Variants with activity higher than 1.2-fold 
times wild-type LacZ, but less than 0.8 times the D201/H540V/N604T mutant were 
identified as improved, but not supermutants.  Those with 0.8-1.2 times the activity of 
D201/H540V/N604T mutant were identified as supermutants.   
4.2.9 Verification of Identity of “Winners” 
All improved and supermutants identified from the unpooled condition, as well as all 
supermutants identified in the pooled conditions, were grown in a 5 mL culture, the 
plasmid retrieved by miniprep, and the colony sequenced (Fundamental and Applied 
Molecular Evolution Center, Emory University) to determine the amino acid sequence.  
A small sample of the improved mutants and those identified as wild-type equivalents 
from the pooled condition were also sequenced to get an estimate of false positive rates. 
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4.3 Results 
 The first goal of this work was to evaluate the sensitivity of the model predictions 
to parameters that might be hard to estimate, or control, for a combinatorial protein 
engineering system.  We were interested both in understanding how changes in the 
estimation of the activity distribution would affect the accuracy of the prediction, as well 
as how the activity ratio and the coefficient of variation of the assay, two parameters 
which are interdependent, would affect the ability to accurately predict the number of 
supermutants detected after pooling.   
 The second goal was to use the model in both pooled and unpooled conditions to 
predict the number of supermutants that would be found after screening the fucosidase 
library.  In doing so, we would need to set a threshold level for the activity of the 
supermutant (in effect, define what a supermutant is for the model).  To determine 
whether the threshold should be set equal to the activity ratio, or slightly below, we 
explored the effect of both definitions on the predictions.  We then compared the 
predicted and experimentally determined number of supermutants at both thresholds.  
4.3.1 Sensitivity to Activity Distribution Input 
Diversity generation by error-prone polymerase chain reaction (epPCR) results in 
sigmoidal shaped curves with a large number of mutants displaying wild-type activity 
and a large number or inactive mutants, the exact shape and steepness of which depend 
on the mutation frequency.  The wild-type activity results from random mutations in 
tolerated positions, or screening of unmutated sequences when the mutation rate is very 
low.  Inactivation is a result of mutation in residues which cannot tolerate substitution 
and can be the result of misfolding or destruction of catalytically important residues.  In 
 62
contrast to epPCR, diversity generation by active site randomization is very disruptive to 
activity because of the proximity of the targeted residues to the catalytic sites.  Thus, 
activity curves from randomization experiments resemble exponential decay curves. 
Three different sigmoidal curves to mimic the type of activity curve obtained from 
epPCR experiments and three different exponential decay curves to mimic the data 
obtained from active site randomization experiments were computationally created 
(Figure 4.2a and Figure 4.2b).  Within the sets of curves, we chose to change the 
maximum value obtained and the steepness of the slopes.  For comparison purposes, the 
average activity level was kept the same for the three curves of each type.  All other 
simulation input parameters were those derived for this study.  Figure 4.2c shows the 
predicted number of supermutants detected for the epPCR curves.  The three curves are 
very similar, with overlapping error bars, indicating that the variance in the activity 
distribution does not have a great effect.  The same similarity in the prediction is seen in 
the estimation of false positives and negatives (data not shown).  Figure 4.2d shows the 
expected number of supermutants predicted by the model for the three curves 
approximating data from an active site randomization experiment.  Here, the three curves 
differ in their predictions much more than with the epPCR curves.   Curve C, which has 
more colonies with zero activity level and a higher activity level of improved mutants, 
predicts far more supermutants than the other two curves; curve B is intermediate.  The 
negligible effect of the shape of the curve in epPCR experiments is expected since all 
three curves have a large mass of activities equivalent to wild-type and completely 
inactive mutants.  These are most often sampled in the random allocation of cells to 
wells, regardless of the other mutants present.  In the case of the exponential decay 
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curves, there are very few identical activities, other than the inactive mutants, so the 
individual identities of the cells have a greater effect on the number of supermutants 
obtained.  
Figure 4.2:  Analysis of dependence of model on shape of activity distribution.  Top left: 
a)  Three sigmoidal curves used to simulate epPCR experiments.  Top right: b)  Three 
exponential decay curves used to simulate active site randomization experiments.  Other 
parameters used as  input:  activity ratio (5), assay coefficient of variation (24%), 
threshold for detection of mutant (5), supermutant:dud ratio (1/8192), number of plates 
per stage (13), all results are the average of 10 simulation experiments.  Bottom left:  c)  
Number of supermutants predicted by the model with each of the epPCR curves.  Bottom 
right:  d)  Number of supermutants predicted by the model with each of the active site 
randomization curves. 
 
4.3.2 Analysis of the Interdependence of Assay Accuracy and Activity Ratio 
 Two important factors in the ability to detect improved mutants while pooling are 
the increase in activity level of the supermutant (activity ratio) and the accuracy of the 
assay.  These are highly interdependent.  For example, if an assay has no error in 
detection (coefficient of variation, CV=0), then the supermutant can always be detected 
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has an infinite level of improvement then it will always be detected even if the assay has 










































































































Figure 4.3:  Predicted number of supermutants at varying activity ratio and coefficient of 
variation.  Top (left to right):  Activity ratio of 5, Activity ratio of 50 Bottom (left to 
right): Activity ratio of 500, Activity ratio of 5000.  Each point represents an average of 
10 simulations. 
 
Figure 4.3 shows the simulated number of supermutants detected at activity ratios 
ranging from 5 to 5000 and CVs from 0 to 50%.  At a CV of zero (long dashed line), the 
assay has no error, so false positives and negatives do not exist.  This represents the true 
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number of supermutants present for that experiment.  At the lowest activity ratio and 20 
cells per well, the model underpredicts the number of supermutants, at all non-zero 
values of CV, as a result of a large number of false negatives.  At the next level of 
activity ratio and above, the number of false negatives diminishes to below one in all 
cases because the threshold is much lower than the activity of the improved mutant and 
the error in detection of the true number of supermutants is due to the detection of false 
positives.  CVs of 5, 10, and 24% give similar predictions at all activity ratios.  The 
highest CV of 50% tends to lead to overprediction of the number of supermutants present 
at all activity ratios. 
4.3.3 Threshold for Detection 
When using the GREATER_THAN function, it is necessary to set a threshold for 
detection of the supermutant.  Lower thresholds will mean fewer false negatives, but 
more false positives, while higher thresholds have the opposite effect.  In general, false 
negatives are more detrimental in the screening of a directed evolution library than false 
positives.  For simulation of detection of the supermutant in our library we chose to 
compare two cutoff points, a threshold of five, which is equal to the activity ratio of the 
supermutant to the wild-type, and a threshold of four to allow for detection of 













































Simulation-False Positives + False Negatives
 
Figure 4.4:  The influence of the threshold for detection in the GREATER_THAN 
function.  Top:  Threshold of 5.  Bottom:  Threshold of 4.  The data points are the mean 
of 100 simulations. 
 
 Figure 4.4 illustrates the effect of changing the threshold from five to four.  At a 
threshold of five (top curve) there are a substantial number of false negatives.   The 
number of false negatives decreases significantly when the threshold is lowered to four 
(bottom curve), but the number of false positives also increases.  The decline in the 
number of supermutants predicted at 50 and 100 cells per well is the result of the capacity 
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of the second stage.   Only a certain number of wells can be sampled from the first stage 
to the second because the number of wells in the second stage is fixed.  Since each well 
must be sampled enough times to retrieve all mutants present (example at least 50 times 
for 50 cells per well), at very high pooling levels some wells that contain a supermutant 
are left behind once the second stage fills up. 
4.3.4 Prediction of Number of Supermutants Detected with Fucosidase Library 
As an equivalent to the filter-lift screening done by Parikh and Matsumura, we 
screened 26 384-well plates, approximately 10,000 colonies, without pooling to create a 
baseline for comparison.  Ten wells turned visibly yellow and were picked for 
confirmation.  In the secondary assay, three of the 10 had activity that was equivalent to 
the supermutant control, three had activity that was higher than wild-type LacZ, but not 
as high as the supermutant, and four had activity equivalent to the wild-type.     
Based on the simulation results in Figure 4.4, we chose to pool 10 cells per well to 
validate the model prediction.  After the first stage assay, 26 wells turned visibly yellow 
and were picked for the secondary assay.  Following the second stage, all 26 wells 
contained a mutant with wild-type or higher activity and the majority of wells (85%) had 
several active variants.  If variants are identified singularly, a total of 8 supermutants, 23 
improved mutants, and 26 wild-type equivalents were obtained after the secondary 
screen.  If the wells are identified by the mutant with the highest level of activity in them, 
8 wells contained supermutants, 14 wells contained improved, but not super-, mutants 
and 4 wells contained wild-type equivalents.   
Sequencing data was used to refine the identification of improved mutants (Table 
4.1).  In the unpooled condition, the six mutants with activity higher than wild-type were 
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sequenced.  Three of these were identified as supermutants by the secondary assay.  All 
three had sequences different than wild-type at the three randomized positives, two had 
sequences identical to the supermutant (D201/H540V/N604T) identified by Parikh and 
Matsumura.9  Three additional wells from the unpooled assay were identified as 
improved, but not supermutants.  Upon sequencing, however, these wells actually 
contained wild-type enzyme, meaning that they were false positives identified in the 
unpooled screen. 
 
Table 4.1:  Sequences of mutants identified in the 384-well plate screen. 
Unpooled Screen     
Secondary Assay Identification D201 H540 N604 Comment 
Supermutant D H P New Sequence 
Supermutant D V T Best mutant from ref 9 
Supermutant D V T Best mutant from ref 9 
Improved D H N  False Positive 
Improved D H N False Positive 
Improved D H N False Positive 
     
Pooled Screen     
Secondary Assay Identification D201 H540 N604 Comment 
Supermutant D A S New Sequence 
Supermutant D E T New Sequence 
Supermutant D E T New Sequence 
Supermutant D V T Best mutant from ref 9 
Supermutant D H N False Positive 
Supermutant D M E New Sequence 
Supermutant D E T New Sequence 
Supermutant D A S New Sequence 
Improved D V T Best mutant from ref 9 
Improved D H N False Positive 
Improved D H N False Positive 
Improved D H N False Positive 
Wild-Type D H N Confirmed WT 





From the pooled experiment, eight wells were identified as having contained 
supermutants at the end of the secondary assay.  The variants from these eight wells were 
all sequenced.  Of these, one was the wild-type enzyme (a false positive), one contained 
the D201/H540V/N604T supermutant, and the additional six wells contained other non-
wild-type sequences.  Of the 14 improved, but not supermutants, a random sample of four 
variants was sequenced.  Three of these were wild-type enzyme false positives, the fourth 
was an improved enzyme.  Two of the four wells identified as having contained wild-type 


























Simulation Threshold 5 Simulation Threshold 4 Experiment
 
Figure 4.5:  A comparison of the predicted and experimentally obtained number of 
supermutants.  The simulation predictions using a threshold of 5 and a threshold of 4 are 
both included for comparison purposes.  The experimental results have been adjusted for 
false positives using sequencing data.    
 
 Figure 4.5 compares the number of supermutants predicted by the simulation 
model with those obtained through experiments at 1 and 10 cells per well.  The model 
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accurately predicted the number of supermutants obtained through pooling when a 
threshold of five was used for the GREATER_THAN function.  When four was used as 
the threshold, the model overpredicted the number of supermutants that would be 
detected, largely because of the presence of about twice as many false positives with the 
lower threshold.  The number of supermutants obtained without pooling is higher than 
predicted.   
4.4 Discussion 
We have shown that it is feasible to use our Monte-Carlo simulation model of the 
pooling process to guide screening experiments with an actual directed evolution library.  
The library, which was randomized in three active site residues, has a broad spectrum of 
activity levels, which prohibits the direct calculation of the probability of finding a 
particular mutant.  Monte-Carlo simulation methods were developed specifically for 
situations such as this, where complexity prohibits direct calculation.  Additionally, we 
have shown that our model can be extended to screening cases that require an induction 
step to express the enzyme being engineered.  Currently, this represents the vast majority 
of cases, although systems that allow for constitutive expression have been developed.11  
In our case, the induction step adds variability to our assay accuracy (a coefficient of 
variation of 24% versus 10%), but we were still able to successfully employ the pooling 
strategy predicted by the simulation model. 
4.4.1 Increase in Number of Supermutants Detected Using Pooling 
Using pooling we obtained more than twice the number of supermutants (seven) 
as in the unpooled condition (three).  In addition, we attained more diversity in the 
sequences obtained with pooling (four different enzymes versus two).  When trying to 
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identify variants that were improved over wild-type, but not supermutants, we found a 
high number of false positives.  All three such variants identified in the unpooled screen 
were false positives, and approximately 75% of those identified when pooling were false 
positives.  Possibly, we set our criteria for improvement (1.2-fold increased activity over 
wild-type) too low given that the coefficient of variation of our assay was 24%. 
4.4.2 When Is Pooling Useful? 
Pooling is especially suited to cases where the average background level of 
activity is very low.  We can envision several scenarios that produce such an activity 
curve.  In the particular instance under study, the library was created by randomization of 
amino acid residues very close to the active site.  This results in an extremely sharp 
activity curve where a large percentage of the mutants are completely inactive.  Thus, 
wells containing good mutants are readily distinguished from those that do not.  A second 
scenario under which one might expect a very sharp activity distribution is when a novel 
function is to be created.  Here, the background level of activity is essentially zero.  In 
addition, the creation of new activity is a very rare event, so many, many samples will 
need to be screened in order to identify those with the created activity.  Thus, pooling will 
be a highly beneficial strategy to increase the efficiency of the process.  Finally, error-
prone polymerase chain libraries with very high mutation rates also produce the same 
type of sharp activity distribution.  In a recent paper, Chodorge et al published data on 
mutation rate versus active fraction for green fluorescent protein and Candida antarctica 




4.4.3 Estimating the Parameters 
4.4.3.1 Activity Distribution 
The activity distribution can be measured by performing a small preliminary 
screen.  In the case of error-prone polymerase chain reaction curves, errors in the 
estimation of the distribution will have little effect on the predicted outcomes.  For active 
site randomization, the impact of errors is higher, however if a random sample is taken, 
this should suffice for prediction purposes. 
4.4.3.2 Supermutant to Dud Ratio 
An additional benefit of diversity generation by active site residue randomization 
is that it provides a simple way to calculate the frequency of occurrence of each mutant, 
thereby allowing you to input the expected value of the rarest mutant as your supermutant 
to dud ratio.  This is a much easier parameter to estimate than the true supermutant to dud 
ratio, which may not be known for a particular experimental system unless prior 
experiments have been conducted.  In the case of variants generated by error-prone 
polymerase chain reaction or by DNA recombination protocols, the frequency of the most 
rarely occurring mutants can also be calculated using formulas such as those derived in 
Patrick et al.13 
4.4.3.3 Activity Ratio 
Another parameter that needs to be estimated is the activity ratio.  In cases where 
prior engineering of the same protein has been done, this parameter can be estimated 
from these experiments.  However, in the case where this is the first attempt to evolve the 
protein, a substitute measure, the minimum activity level that is an acceptable outcome, 
may be used.  
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4.4.3.4 Threshold for GREATER_THAN Function 
The threshold of detection for the GREATER_THAN function can be raised and 
lowered to aid in choosing a pooling level.  In general, the higher thresholds yield more 
false negatives and lower thresholds yield more false positives. 
One additional note in the optimization of the pooling level is that the more false 
positives the experimenter is willing to accept, the more cells that can be pooled into each 
well.  In early rounds of evolution, it might be beneficial to accept more false positives so 
that a larger portion of the library can be screened in order to find very rare mutants with 
the activity of interest.  On the other hand, there may be less tolerance for false positives 
in later rounds when fine-tuning of the protein properties is the most important factor. 
4.4.4 Extension of Model to Other Disciplines 
The Monte-Carlo simulation model of pooling that we developed is adaptable for 
design of experiments in other disciplines as well.  In the example of pooled blood 
samples being tested for a foreign agent, the situation is analogous to the search for a 
supermutant among the population using the SUPERMUTANT function.  The inputs here 
would be the estimated frequency of occurrence of tainted blood (such as a prevalence 
rate), the level of signal achieved by a positive sample, the number of samples that will 
be pooled together, and an estimate of the variation in the assay procedure.  Similarly, a 
combinatorial library of chemicals derived from a lead structure is similar to a library of 
enzymes being evolved towards higher function.  The inputs would be similar to those 
required in this study.  In such experiments, often the level of activity of the base 
compound is already known.  Therefore, one could use the GREATER_THAN function 
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to screen for compounds with higher activity than the lead.  In this situation, the activity 
distribution could be determined by a small-scale assay of a handful of compounds.   
4.5 Conclusions 
Pooling is a means to increase the efficiency of screening experiments by 
increasing the throughput (and by consequence allowing for sampling of more diversity), 
or by extending a limited screening capacity to analyze a larger library.  The evolution of 
β-galactosidase to β-fucosidase by Zhang et al required seven rounds of evolution with 
screening of 10,000 colonies per round.10  With a conservative estimate of three days per 
round of diversity generation followed by two days per round of screening, the total time 
estimate for the study was 35 days.  In contrast, Parikh and Matsumura were able to 
achieve higher activity in one round of evolution with screening 10,000 colonies, for an 
approximate total time of five days.9  In the same amount of time, and with an equivalent 
amount of effort, we were able to screen five times as many colonies using pooling in 
384-well plates.  The gain in screening capacity could have been further increased if we 
had allowed an unequal distribution of capacity across the two stages (please see Chapter 
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In many cases, the objective of expressing a protein is to purify and characterize it to 
learn its function or to use it as a catalyst for a desired reaction.  When doing so, the goal 
is to obtain a very high level of expression so that the highest possible yield is obtained 
from each experiment.  The protein may also be affinity tagged for easy purification.  The 
culture volume in such an experiment are in general very large, on the order of liters, and 
the organisms are grown to very high cell densities often using baffled flasks for high 
levels of aeration.  Most commercially available expression plasmids are developed with 
this purpose in mind.  In contrast, protein expression for high throughput screening takes 
place in well-plates which contain small culture volumes, on the order of microliters, and 
may be poorly aerated.  The goal here is also different—to make measurements of 
activity as quickly as possible and with the highest amount of information garnered in 
each measurement.  Thus, the toolbox for protein expression differs for high-throughput 
applications and requires the development of expression vectors geared towards this 
purpose.  The goal of this work is to assemble a collection of vectors formulated for the 




5.2 Discussion of Vector Features 
5.2.1 Basic elements necessary for protein expression 
5.2.1.1 Origin of Replication 
All expression plasmids contain certain necessary elements.  First and foremost, 
the plasmid must have an origin of replication which directs its own copying and 
propagation to future generations.  The origin also controls the frequency of replication, 
and therefore, the average number of plasmid copies that are maintained within the cell.  
A high-copy plasmid is one that is present in 100 copies or more within the cell, while a 
low-copy plasmid is usually maintained at less than 5 copies per cell.  Intermediate copy 
numbers are called medium-copy.  While higher copy number results in higher protein 
production, high-copy plasmids represent a large metabolic burden on the cell, and as a 
result can be highly unstable.1  
5.2.1.2 Promoter and Operator 
All expression vectors also require a mechanism to initiate transcription, the 
precursor to protein production.  The promoter is a particular nucleotide sequence 
positioned 10 to 100 base pairs upstream of the ribosome binding site.  In E. coli, most 
promoters contain two conserved hexanucleotide sequences, one at -10 bp and the other 
at -35 bp from the start of transcription.  The regulation of the promoter (on/off switch) is 
controlled by the operator region, which is recognized by repressors (turn off 
transcription) and inducers (turn on transcription).2 
Most traditionally used expression vectors contain a lac promoter/operator 
derived from the E. coli metabolic machinery for lactose metabolism.  The main 
disadvantage to this system is that it is part of the innate cellular metabolism.  This results 
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in a high level of background, or “leaky” transcription resulting from incomplete 
repression because some of the naturally produced repressor is used to control the 
naturally occurring operon.  In addition, full scale induction of this promoter to produce 
protein also results in induction of the naturally occurring genes, and results in unwanted 
metabolic changes to the cell.  An alternative, orthogonal, promoter/operator system is 
derived from the (Tn10) tet operon.  The tet system is characterized by extremely tight 
repression, followed by linear induction in response to inducer over a 5000-fold range.3  
In addition, the best inducer for this promoter/operator is anhydrotetracycline, which can 
be economically produced by autoclaving tetracycline at low pH.4   
5.2.1.3 Constitutive vs. Inducible Expression 
Constitutive protein expression is very important in high throughput screening 
systems because an induction step requires additional handling which decreases the 
efficiency of the screen.  The ability to vary the level of expression as evolution 
progresses is also of interest.  This allows for high levels of expression in early rounds of 
directed evolution when the level of activity is low (thereby increasing the overall signal) 
tapering to lower levels of expression in later rounds so that small increases in an activity 
can still be detected (increases the dynamic range).  The level of expression can also be 
tuned to modulate toxicity of the protein being expressed and to decrease overall 
metabolic burden.5 
One method to create a library of vectors with varying levels of expression is to 
randomize portions of the promoter sequence.  One such approach was undertaken by 
Matsumura et. al., who randomized six conserved nucleotides in the – 10 region of the lac 
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promoter in pET20, which resulted in a spectrum of expression levels ranging over three 
orders of magnitude.5  
5.2.1.4 Ribosome Binding Site 
Finally, in order to have translation of the gene of interest into a protein, each plasmid 
must contain a ribosome binding site for initiation of protein production.  Though there is 
some evidence that the level of expression changes with the particular sequence of the 
ribosome binding site and the spacing of the initiation codon of the protein from it, most 
commercial vectors contain a standardized ribosome binding site with a 5 to 13 
nucleotide spacer.  This is sufficiently optimized for protein production in most cases.2   
5.2.1.5 Base Vector to Provide These Elements 
We chose to use the commercially available pPROTet vector as a base for 
constructing the high throughput screening vectors.  The vector has a ColE1 origin, 
which maintains a high copy number, a tet promoter/operator, and a ribosome binding 
site.  In this case, the high copy number should not cause toxicity problems due to the 
tunability of expression level in response to the inducer anhydrotetracycline.  The 
multiple cloning site allows for cloning of a gene with an N-terminal 6XHN tag 
(alternating histidine and asparginine), however, this was removed during vector 
construction.  We also explored the idea of trading the tet promoter/operator, for a lac 
system that was randomized in the operator region to produce variable levels of 
constitutive expression. 
5.2.2 Selection for Plasmid Retention 
For efficient overexpression of the protein of interest, it is necessary to have some 
mechanism which causes the plasmid to be retained by the cell.  The same mechanism 
 81
can also be used to select for colonies containing the plasmid in the initial cloning step.  
Plasmid loss is extremely detrimental to high density fermentation systems and is more 
likely to occur with high-copy plasmids or when the expression of the gene is toxic or 
interferes with cellular growth.6 
5.2.2.1 Antibiotic Resistance Genes 
The most widespread method to ensure plasmid uptake and retention is the use of a 
plasmid-borne antibiotic resistance marker, which confers resistance to an antibiotic of 
choice when the plasmid is present in the cell.  The main problem with such a selection 
method is that antibiotics are degraded and/or inactivated by these enzymes, which leads 
to reduced pressure to maintain the plasmid as the fermentation progresses.7  In addition, 
the promoter systems controlling the antibiotic resistance genes are constitutively active, 
usually at a very high level, causing a high metabolic burden on the cell.8  Thus, when the 
selective pressure is diminished, it is advantageous for the cell to release the plasmid. 
5.2.2.2 Growth Inhibitors 
To construct our vectors, we focused on the use of a cellular growth inhibitor to drive 
plasmid maintenance.  The main advantage here is that the bacteria survive via an 
alternate metabolic gene provided on the plasmid which is not sensitive to the inhibitor, 
thus the inhibitor is not degraded or inactivated by the mechanism of selection.  This 
means a constant concentration of inhibitor will be present throughout the fermentation, 






Triclosan, the active ingredient in antibiotic soaps and in toothpaste, is an inhibitor of 
the lipid biosynthetic enzyme enoyl-acyl carrier protein reductase (ACP reductase) of E. 
coli.  Triclosan is effective at a concentration of less than 10 ppm, thus only a low level 
of inhibitor is necessary to maintain selective pressure.  Variants of ACP reductase from 
some other organisms are not inhibited by triclosan and a cloning vector containing the 
Bacillus subtilis ACP reductase and its natural promoter has been demonstrated to confer 
resistance to triclosan up to 10,000 ppm when expressed in E. coli.9  We focused on using 
this enzyme to maintain plasmid selection. 
5.2.3 Mechanism of DNA Insertion 
All vectors must have a mechanism to insert the DNA of interest.  Most often, this is 
done by using restriction enzymes to digest both the vector and the DNA fragment to 
produce complementary ends that are ligated together.  Most modern vectors have a 
region, called the multiple cloning site, which is rich in sequences recognized by 
common restriction enzymes.  One of the limits of traditional cloning is that the 
restriction enzymes chosen must only cut the DNA of interest in the intended place and 
since there are a limited number of reliable restriction enzymes some genes can be very 
problematic to clone.  Additionally, the efficiency of insertion of DNA by traditional 
methods is affected by the efficiency of each of the enzymatic steps (digestion and 
ligation), which can result in a high background level of plasmid that does not contain the 




5.2.3.1 Ligation-Independent Cloning 
 Ligation-independent cloning (LIC) is a method of gene insertion that does not 
rely on restriction enzyme digestion and ligation.  Rather, complementary 12-18 bp 
overhangs are generated on both the insert and the vector.  These are allowed to anneal 
and the vector is then transformed into cells where repair of the nicks occurs to create a 
fully circularized plasmid.  The overhangs can be generated in several ways.  
Commercial LIC vectors rely on the 3’ to 5’ exonuclease activity of T4 DNA polymerase 
to generate the overhangs.  With this method, a sequence rich in three of the four 
nucleotides is required and incubation of the DNA with the enzyme and the fourth 
nucleotide results in base excision until the nucleotide is encountered, followed by an 
equilibrium of insertion and deletion which controls the length of the overhang.10  
Another approach is to use a short digestion with exonuclease to create the overhangs, 
though this can result in a spectrum of overhang sizes that reduces the efficiency of 
cloning.11  Finally overhangs can be generated directly during PCR by use of hetero-
staggered primers12, incorporating RNA bases into a primer which are not copied by the 
polymerase13, or truncation of the PCR using an atypical nucleotide.14 
5.2.4 Expression Reporters 
Visualization of the ability of an individual clone to express the protein of interest, as 
well as a crude measurement of the level of that expression can be obtained using a 
fluorescent protein as an expression reporter.  Several such proteins exist.  The most well 
known is the green fluorescent protein (GFP) a non-enzymatic protein found in jellyfish 
such as the species Aequorea.  Depending on the variant in question, GFP has a range of 
excitation values, from the long-range ultraviolet through around 490 nm, and an 
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emission wavelength in the green area, usually between 504-511 nm.  Various mutants of 
GFP have also been created, these include cyan, blue, and yellow fluorescent versions 
with emissions wavelengths in the areas of their respective colors.15  The use of GFP as 
an expression reporter in an operonic system (i.e. transcriptionally fused, but 
translationally distinct)16 and as a fusion protein with a protein of interest17 has been 
reported.  
Another class of fluorescent proteins is derived from the Discosoma species of coral, 
and fluoresces in the red region, around 600 nm.  The original protein, DsRed, is a 
tetrameric enzyme18, but monomeric variants of this protein have been evolved via 
directed evolution.19  In addition, the monomeric red fluorescent protein has been evolved 
to a rainbow of colors, ranging from red to green.20  
5.2.5 Folding Reporters 
Selection for proper folding can be achieved by the C-terminal fusion to a protein 
that can report the state of the protein of interest.  The premise is that in order for the 
reporter protein to fold, the protein of interest must be properly folded. 
5.2.5.1 Fluorescent Proteins 
The use of GFP as a folding reporter was studied extensively by Waldo et al, who 
showed via studies with 20 different proteins that the level of GFP fluorescence could be 
correlated with the likelihood that the protein of interest would aggregate.21 
5.2.5.2 Antibiotic Resistance Markers 
An additional class of proteins that can be used as folding reporters are genes 
conferring resistance to an antibiotic.  These can be used to select for properly folded 
mutants by plating on medium containing the antibiotic.  Those transformants containing 
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properly folded proteins will be resistant, and as a consequence, will grow, whereas those 
with misfolded proteins will not be resistant and will die.  One example used the 
chloramphenicol acetyl-transferase gene to select for mutants of HIV integrase that were 
more soluble.22 
5.2.5.3 Intein-Mediated Fusions 
Finally, one strategy that allows for fusion tag monitoring of folding, followed by 
purification of the protein of interest without purification of the reporter protein is to use 
an intein-mediated fusion.  Inteins are self-excising protein elements which will cleave 
themselves out of proteins when some chemical or physical cue is received.  Some inteins 
splice the protein halves together as they are cleaved, but modified inteins have been 
created which excise without splicing, thereby leaving the protein of interest free in 
solution.  This strategy has been used with GFP and can include a purification tag such as 
a hexahistidine or chitin-binding domain which can be used to trap the protein of interest 
for purification following cleavage.7 
5.3 Materials and Methods 
5.3.1 Materials 
Molecular biology reagents (restriction enzymes, ligase, polymerases) were 
obtained from Fermentas (Hanover, MD) through VWR International (Suwanee, GA).  
Primers were synthesized by MWG Biotech (High Point, NC).  The pPROTet 6XHN and 
GFPuv vectors were purchased from BD Biosciences Clontech (Mountain View, CA).  
The SuperGlo TM vector was obtained from Qbiogene (Irvine, CA).  The pET32 Ek/LIC 
cloning kit was purchased from Novagen (San Diego, CA).  The pBBRT vector was a 
kind gift from Dr. Anthony Hay (Cornell University, Ithaca, NY)9.  The Qiaprep Spin 
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Minprep Kit and Qiaquick Gel Extraction Kit were purchased from Qiagen (Valencia, 
CA).  Fluorimetric measurements were made using a Fluorostar plate reader (BMG 
Technologies, Offenburg, Germany).  The rapidly maturing DsRed variant was a kind 
gift from Dr. Benjamin Glick (University of Chicago, Chicago, IL)18.  The mRFP gene 
was synthesized and cloned by fellow lab member Bernard Loo.   
5.3.2 Test of Ligation-Independent Cloning Efficiency 
The basic experimental procedure for LIC using T4 DNA polymerase to generate the 
overhanging ends was tested using the pET32 Ek/LIC cloning kit from Novagen 
according to the manufacturer’s instructions using DsRed as a test insert.  The 
experimental annealing reaction consisted of 1 µl of linearized plasmid provided with the 
kit, and 2 µl of the prepared insert.  A control experiment was set up using the linearized 
vector provided with the kit and 2 µl of water.  Following annealing and transformation, 
40 µl of both annealing reactions were plated on LB media containing ampicillin to select 
for the plasmid.  The resulting colonies were miniprepped and analyzed by restriction 
digest to determine the presence of insert.   
5.3.3 Insertion of Triclosan into pPROTet 
The chloramphenicol resistance gene on pPROTet was replaced with the ACP 
reductase gene from the pBBRT vector using overlap extension PCR.  Two fragments 
were generated by PCR, the ACP reductase gene including its promoter, and the 
pPROTet vector minus the chloramphenicol acetyl transferase gene and its promoter.  
The fragments were gel purified and mixed in equimolar ratios for the primerless 
extension PCR.  The product of the overlap extension reaction was transformed directly 
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into DH5α(PRO) cells and plated onto LB containing 2 µg/ml triclosan to select for 
successful transformants.  Insertion of the triclosan gene was confirmed by sequencing.   
5.3.4 Design of LIC Inserts 
Novel LIC sites were designed using VectorNTI (Invitrogen, Carlsbad, CA) and 
synthesized from complementary primers by melting the DNA at 95 °C and reannealing 
by slowly bringing the temperature down to 25°C.  The DNA fragments were stored at  
-20°C.  
5.3.5 Randomization of the lac operator 
Whole plasmid amplification by PCR using randomized primers was performed 
using the Roche High Fidelity Long-Range PCR kit on DsRed-pET32 according to the 
manufacturer’s protocol.   A good concentration of a single product of the correct size 
was obtained.  The amplified plasmids were transformed into electrocompetent E. coli 
DH5α.  Colonies from the transformation were picked into single wells of a 96-well plate 
containing 200 µl of LB plus ampicillin and supplemented with 30% glycerol using 
sterile toothpicks.  The plates were grown at 30 °C for 48 to 72 hours and expression was 
tested by fluorimetry.   
5.3.6 Fluorescent Reporter Tests 
The DsRed and GFPuv genes were amplified via PCR and cloned into the pET32 
Ek/LIC vector.  The plasmids pET32-DsRed, pET32-GFPuv, and pQBP1-T7-SupergloTM 
GFP were transformed into E. coli DH5α and their fluorescence tested by induction with 
IPTG.  pPROTet-mRFP was transformed into DH5α(PRO) and induced with autoclaved 
tetracycline.  GFPuv was excited with a handheld UV light at 365 nm, the other proteins 
were excited with a full spectrum of light.     
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5.3.7 Intein-Mediated Fusion Proteins 
The intein fusion proteins were designed according to Zhang et al, but substituting 
mRFP for the green fluorescent protein and including a LIC site for gene cloning (see 
Figure 5.1).7  In addition, the option for a 6XHN-tag as an alternative to the chitin-




Figure 5.1:  Intein-Mediated Fusion Reporter Construct 
 
The individual genes were amplified by PCR and the full construct assembled by overlap 
extension PCR.  The presence of each piece was confirmed by a PCR using primers 
specific for that portion and the full construct was sequenced to determine whether point 
mutations were present.  The LIC site was linearized by digestion with SspI for 16 hours 
at 37°C and the overhangs generated by treatment with T4 DNA polymerase and dCTP at 
25°C for 1 hour.  As a test insert, β-lactamase was amplified by PCR with primers coding 
for complementary overhangs to the LIC site.  The PCR product was gel purified and 
treated with T4 DNA polymerase and dGTP for 1 hour at 25°C.  Two µl of the treated 
insert and 1 µl the treated vector were annealed at 22°C for 30 minutes and the annealing 
reaction was terminated by addition of 1 µl of 25 mM EDTA.  The annealed vector was 
transformed into DH5α(PRO) competent cells.  The expression of the mRFP gene was 
Tet Promoter/Operator and RBS 
mRFP 
NEB Ssp DnaE intein halves 
Chitin Binding Domain/ His Tag 
Ligation Independent Cloning Site for Gene of interest 
pPROTET comprised the body of the vector 
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induced with autoclaved tetracycline both before and after insertion of the β-lactamase 
gene.  The expression level of the fusion construct was evaluated by the fluorescence 
level of the mRFP and by SDS-PAGE gel.        
5.4 Results 
5.4.1 Insertion of the Triclosan Gene into pPROTet 
 The chloramphenicol acetyl transferase gene was successfully replaced in 
pPROTet by the ACP reductase gene as evidenced by the ability of cells containing the 
plasmid to grow on medium containing triclosan, but not on medium containing 
chloramphenicol.  Sequencing results also confirmed that the correct gene was inserted. 
5.4.2 Test of LIC Efficiency 
The efficiency of the LIC procedure was tested using the commercially available 
pET32 Ek/LIC kit.  A negative control reaction using water in place of treated insert was 
also run.  From 40 µl of transformation reaction plated onto LB medium plus ampicillin, 
six colonies were obtained.  When these were analyzed further, no inserts were obtained, 
and in the case of 4 of these, the plasmid obtained was not consistent with the pET32 
plasmid on the basis of size.  From 40 µl of transformation reaction plated from the 
annealing reaction containing insert, thirty-nine colonies were obtained.  Upon further 
analyses, 36 of these contained the correct DsRed fragment, for an efficiency of 92%.   
5.4.3 Design of LIC Inserts 
 The first LIC site was designed to allow for the use of a C-terminal 6X Histidine 
tag with the protein of interest (Figure 5.2).  It is linearized by the restriction enzyme SspI 
(blue) to begin T4 DNA polymerase treatment and is flanked by EcoRI sites (red).   
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GAATTCATTAAGAGGAGAAAGAGAATATTCACCATCATCATCATCATGGAATTC    




The second LIC site does not provide for a C-terminal His-tag and has shorter 
overhangs (Figure 5.3).  It is linearized using SrfI or SmaI (blue) and is flanked by KpnI 
sites (red). 
 
GGTACCGGCCCCGGAGCCCGGGCGGCGGCTTAGGTACC    
CCATGGCCGGGGCCTCGGGCCCGCCGCCGAATCCATGG 
 
Both LIC sites were assembled and inserted into the pPROTet vector.  Linearization was 
tested using the appropriate restriction enzyme.  The SmaI enzyme did not digest as 
efficiently as the SspI enzyme, as evidenced by multiple bands being present on the gel 
following digestion.  Additionally, the sequence of the second LIC site is very G/C rich, 
so further experiments used the first LIC site. 
5.4.4 Constitutive Expression by Randomization of the lac Operator 
Following the randomization procedure, single colonies were picked to the wells of five 
sets of 96-well plates and grown at 30 °C.  Each plate also contained a medium only 
control as well as a native plasmid (one which was not randomized by PCR).  
Fluorometric measurements were taken at 48 hours (Figure 5.4) and then again at 72 
hours (data not shown).   
 
Figure 5.2:  Designed LIC site allowing for C-terminal His-tag option 
Figure 5.3:  The second designed LIC site without His-tag 
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Fluorescence - Native Plasmid
 
Figure 5.4:  Results of variable expression by randomization of the lac operator region 
 
The range of fluorescence values after 48 hours was rather limited (-10 to 70 units), and 
spanned 1.5 orders of magnitude.  This is inferior to the method of randomizing the 
promoter region.5  In addition, the fluorescence obtained was extremely low, indicating a 
high metabolic burden on the cells to produce protein.   
5.4.5 Fluorescent Reporter Tests 
Each of the potential fluorescent reporters was successfully expressed in both 
liquid and solid medium.  Figures 5.5a through 5.5d show the visual fluorescence test of 














Figure 5.5:  Fluorescent reporter tests.  Clockwise from top left: a) expression of 
the DsRed T3 Mutant (Glick) in E. coli DH5α, b) expression of GFPuv (Clontech) 
in E. coli DH5α, c) Expression of SuperGloTM in E.coli DH5α, d) Expression of 
mRFP in E. coli DH5a(PRO) cells. 
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5.4.6 Intein-Mediated Fusion Proteins 
A diagnostic PCR showed that each piece of the fusion construct was present in 
more than one of the plasmids picked for analysis (Figure 5.6).   
 
 
Unfortunately, none of the colonies were able to visibly express mRFP.  Since it was 
possible that this was due to a protein production issue, as there was no gene of interest 
cloned in with a stop codon to terminate translation, β-lactamase was cloned in as a test 
Figure 5.6:  Diagnostic PCR of intein fusion constructs.  Top from left:  Ladder, 
pKMPa 1-4 PCR to check for chitin-binding domain, pKMPa 1-4 PCR to check 
for mRFP.  Bottom from left:  Ladder, pKMPa PCR to check for pPROTet plus 
triclosan including LIC site. 
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protein.  None of these colonies produced visible mRFP either.  Two colonies were 
overexpressed to check for the presence of protein expression.  There is some evidence of 
insoluble expression, meaning that the fusion protein does not fold correctly. 
5.5 Summary and Conclusions 
 The aim of this work was to develop expression systems that are amenable to 
high-throughput screening situations found in directed evolution.  When proteins are 
being expressed in a high-throughput manner, the goals and problems differ from 
expression for purification and characterization.  Instead of large culture volumes and 
high levels of overexpression, high throughput systems require small volumes, stable 
expression systems, and information density in measurements.  It is of interest to tell 
whether the protein being expressed is folding correctly and the amount of expression is 
useful for estimating specific activities.  Thus, we set out to combine these features into 
an expression system that would support our directed evolution activities. 
The commercially available pPROTet vector was chosen as a base vector because 
it is small and already contains the tet operator/promoter region, as well as providing the 
necessary origin of replication.  Although high copy plasmids can be toxic to cells, in this 
case the ability to induce expression at lower levels using anhydrotetracycline mitigates 
the problem.  The antibiotic selection mechanism (chloramphenicol acetyl transferase) 
was successfully replaced with the triclosan resistance gene using overlap extension PCR.  
Four fluorescent reporter genes were successfully expressed and one, mRFP, was inserted 
into pPROTet as an expression reporter.  Use of an intein-mediated fusion of mRFP as a 
folding reporter yielded solely insoluble expression.  Recent work has shown that the 
original mRFP is not very tolerant in fusion proteins, but changing the termini to be more 
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similar to GFP can increase the tolerance to fusion with another protein.20  This is one 
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6.1.1 α/β-barrel enzymes 
α/β-barrel enzymes are among the most ubiquitous protein folds in nature.  Of the 
currently solved crystal structures of proteins, approximately 10% adopt this structure; 
the majority of these are enzymes.  The range of reactions catalyzed by α/β-barrel 
enzymes is quite diverse; members of this fold can be found in five of the six enzyme 
classes (only class six, the ligases, are absent to date).  Additionally, a few non-enzymatic 
α/β-barrel proteins, such as narbonin, a storage globulin, and concanavalin B, a chitin-
binding protein, have been identified.2   
The classical α/β-barrel enzyme consists of an inner core of 8 β-strands 
surrounded by an outer core of 8 α-helices (Figure 6.1).1-5   In addition, there are quite a 
few related structures (deemed ‘cousins’5) that have added or subtracted helices or 





 Several common motifs occur in a large proportion of the α/β-barrel enzymes, 
despite their chemical diversity.  The active site varies as to which amino acid residues 
are involved, but is always located at the C-terminal end of the barrel in the loop 
regions.1-5  Architecturally, the loops responsible for function and those responsible for 
the stability of the enzyme are separated, with the former being those that connect the end 
of a β-strand to the beginning of the next α-helix, and the latter being the loops 
connecting the end of an α-helix to the beginning of the next β-strand (red and blue 
arrows of Figure 6.1).1  In addition, approximately two-thirds of the α/β-barrel enzyme 
families that have been characterized to date have a phosphate binding group.  These are 
used to bind substrates and/or cofactors that contain a phosphate group and are located 
primarily towards the C-terminus of the protein in β-strand-α-helix pair 7 or 8.  Finally, 
about one-half of the known α/β-barrel enzymes use a metal ion in their catalytic scheme.  
The location of the residues responsible for coordinating the metal ion do vary from 
Figure 6.1:  The structure of an α/β-barrel enzyme.1  The blue arrow denotes a 
loop connecting a beta-strand to an alpha-helix (function).  The red arrow 
denotes a loop connecting an alpha-helix to a beta-strand (stability). 
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protein to protein, but may be conserved among closely related members of the same 
superfamily.2   
α/β-barrel enzymes make a good template for protein engineering for several reasons. 
First, the fact that natural examples exist with very diverse chemistries indicates that 
almost any function can be supported on this template.  Second, since a large portion of 
the residues are involved in the core structure (i.e. form α-helices and β-strands), these 
residues can remain untouched in diversity generation steps, limiting the library size to 
more manageable numbers.  Further, since the loop residues responsible for stability and 
function are physically separated, it should be possible to engineer a different function 
without decreasing the stability of the fold.   
6.1.2 Superfamilies   
A superfamily is a group of structurally-related, sometimes functionally diverse, 
enzymes that catalyze a common reaction or partial reaction step using conserved active 
site residues.6  Typically, members of the same superfamily will have a sequence identity 
of less than 50%7 and very often the identity level is less than 20%.6  What unifies 
members of the superfamily is their conserved chemistry and a similar tertiary structure.  
In fact, the structures of enzymes of the same superfamily are often so superimposable 
that a template can be developed based on a handful of structural similarities among a 
portion of the superfamily that can later be used to identify other members, including 
putative proteins.8  Recent work by Livesay et al seems to suggest that the conserved 
chemistry is, at least in part, due to conserved electrostatic properties across the protein 
structure, despite the actual identities of the amino acids involved.9 
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6.1.3 Enolase Superfamily 
The enolase superfamily is a group of α/β-barrel enzymes that share a common 
partial reaction step, the abstraction of an α-proton from a substrate, followed by the 
formation and stabilization of an enolate anion intermediate.  The chemistry that follows 
the generation of the enolate anion is very diverse, including racemization, elimination of 
water or ammonia (with different stereoselectivity regarding syn versus anti, depending 
on case), and cycloisomerization.10  Members of the enolase superfamily can currently be 
divided into three subgroups based on the identity of the metal ligand groups and the 
residues responsible for catalysis:  the enolase subgroup, which consists of a large 
number of enolases, the mandelate racemase subgroup, which includes mandelate 
racemase and several sugar acid dehydratases, and the muconate lactonizing subgroup, 
which contains muconate lactonizing enzyme, ortho-succinyl benzoate synthase, and N-
acetyl amino acid racemase.10   
Each member of the enolase superfamily has a coordinated divalent metal ion 
(usually Mg++), held in place by three acidic residues.  This metal ion assists in forming 
the enolate anion intermediate of the substrate.  Note that the metal ion is absolutely 
required as the pKas of the abstracted proton of the substrate range from 29 to 32, making 
formation of the enolic intermediate thermodynamically unfavored in the absence of the 
metal ion.6  In general, all reactions in the enolase superfamily use an acid/base chemical 
mechanism, but the identity and location of the general acid catalysis residues differs 
depending on the particular enzyme, including dual lysine residues on opposite faces of 
the substrate (example, muconate lactonizing enzyme), a single lysine residue coupled 
with an additional coordinated magnesium ion (example, enolase), and a 
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histidine/aspartic acid dyad also on opposite faces of the substrate (example, mandelate 
racemase).3  The electrostatic properties of the enzymes differ among subgroup as well 
and can be used to distinguish members of different subgroups.9       
The enolase superfamily is a good choice for an α/β-barrel enzyme template because 
of the chemical diversity of the reactions catalyzed by its members, which allows for 
several diverse evolution targets.  In addition, there is such a high degree of structural 
similarity among the superfamily that the crystal structures from each of the subgroups 
are completely superimposable, with their active site residues and metal ligands aligning 
on top of each other,11 this suggests that changing residues in the substrate binding region 
should allow for catalysis of the new substrate with the existing active site, allowing for a 
semi-rational design strategy.  Additional data from superimposition shows a large 
amount of structural conservation in other regions of the protein, with most of the 
variation in two outer loop regions and in the upper right quadrant of the structures, 
suggesting that these areas should be targeted for changing the substrate binding.7  
Finally, previous work by Schmidt et. al. shows that a single amino acid mutation which 
relaxes the substrate specificity of the enzyme is sufficient to change the reaction 
catalyzed by two different members of the enolase superfamily to a reaction catalyzed by 
a third,12 lending credence to the strategy of changing substrate binding to evolve new 
function. 
6.1.4 Enolase 
Enolase catalyzes the penultimate step in the glycolytic pathway of central 












The enzyme is ubiquitous; found in all organisms from single-celled microbes to higher 
eukaryotes.13  The enolases thus far identified from eukaryotes have all been dimeric in 
tertiary structure, as is the enolase Eschericia coli.   Recently, however, several 
prokaryotic enzymes have been identified with an octameric structure, including those 
from Bacillus subtilis, Streptococcus mutans, Zymomonas mobilus, and Thermus 
aquaticus.14  
The exact mechanism of catalysis for enolase is still under study.  The formation 
of the enolate anion intermediate is thought to begin with abstraction of the α-proton by 
the ε-amino group of a lysine at the end of the 6th beta-strand (K345)11 which in crystal 
structures is shown to be positioned near the proton of 2-phosphoglyceric acid 15.  
Enolase also requires the presence of two divalent metal ions per subunit (usually Mg++) 
for catalysis to occur.11, 15  One of these magnesium ions is a permanent part of the 
structure and is coordinated by the side chains of three aspartic and glutamic acid 
residues (D246, E295, and D320).11  The second magnesium ion adds after the substrate 
has been bound and probably aids in decreasing the pKa of the proton to aid in its 
abstraction.15   
The second step in catalysis is the anti β-elimination of a hydroxyl ion, most 
likely due to an acid/base catalytic mechanism.  Here, the most likely participant is a 
glutamic acid residue (E211) which activates the water molecule for attack.  Electron 
Figure 6.2:  The reaction catalyzed by enolase.  2-phosphoglyceric acid 
(left) is converted to phosphoenolpyruvate (right). 
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density of the hydroxyl group of the substrate is visibly directed towards this residue in 
the crystal structure of yeast enolase.  Other important residues, identified by loss of 
activity in site-directed mutants are E168, K396 and S39.15  The latter is thought to 
regulate loop movement upon substrate binding to yield the closed form of the enzyme, 
promoting catalysis.16 
This work focuses on the enolase enzyme from E. coli, Saccharomyces cerevisiae, 
Lactococcus lactis, and Lactobacillus plantarum.  The enolases from both E. coli and S. 
cerevisiae have been extensively studied and are well characterized.17, 18  In L. lactis, the 
presence of two isoforms of enolase has been noted, one of which is thought be plasmid-
mediated and to have been acquired by lateral gene transfer from Streptococcus 
thermophilus.19  In addition, enolase activity has been demonstrated in whole cell lysate 
grown in the presence of glucose and galactose.20  No characterization of the 
Lactobacillus plantarum enolase has been reported, however, a patent reporting its 
transport to the cellular surface does exist.21       
The purpose of this work is to clone and overexpress the enolase genes from E. coli, 
Saccharomyces cerevisiae, Lactococcus lactis, and Lactobacillus plantarum in 
preparation for their use as templates for directed evolution. 
 
6.2 Materials and Methods 
6.2.1 Materials 
Lactococcus lactis (ATCC #19435), Lactobacillus plantarum (ATCC #10012), and S. 
cerevisiae prepared genomic DNA were purchased from the American Type Culture 
Collection (Manassas, VA).  Phosphoenolpyruvate was obtained from Alfa Aesar (Ward 
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Hill, MA).  Bacterial culture medium, antibiotics, IPTG, and Fermentas brand restriction 
enzymes and T4 DNA ligase were purchased from VWR International (Suwanee, GA).  
All other chemical reagents were purchased from Sigma Aldrich (St. Louis, MO).    The 
Failsafe PCR enzyme and Premix Buffer A were obtained from Epicentre 
Biotechnologies (Madison, WI).  Primers were synthesized by MWG Biotech (High 
Point, NC).  The E. coli BL21(DE3-RIL) expression strain was purchased from 
Stratagene (La Jolla, CA).  The pET 30 Ek/LIC kit was obtained from Novagen (San 
Diego, CA).  The gel extraction kit and Talon Metal Affinity resin were purchased from 
Qiagen (Valencia, CA).  The pET 30 Ek/LIC kit, the Talon Metal Affinity Resin, and the 
gel extraction kit were used according to the manufacturer’s instructions.  Polarimetric 
measurements were taken with a Jasco, Inc. P-1010 polarimeter (Eastman, MD).  
Spectrophotometric measurements were taken with a DU-800 spectrophotometer from 
Beckman-Coulter (Fullerton, CA).   
6.2.2 Isolation of the Enolase Genes 
Genomic DNA from E.coli, L. lactis, and L. plantarum was prepared using the 
method developed by Murphy.22  Blunt-end PCR primers were designed for the initial 
cloning out of genomic DNA.  Two genes were annotated as enolases in the L. plantarum 
genome; both were cloned.   Despite the existence of two enolase genes in L. lactis,19 
only the sequence corresponding to the ancestral gene was cloned (enoA).  The primer 
sequences are as follows: 
E. coli:   Forward ATG TCC AAA ATC GTA AAA ATC ATC G 
  Reverse TTA TGC CTG GCC TTT GAT CTC 
S. cerevisiae: Forward ATG GCT GTC TCT AAA GTT TAC GCT AG 
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  Reverse TTA TAA TTT GTC ACC GTG GTG G 
L. lactis: Forward ATG TCA ATT ATT ACT GAT ATT TAT GCT CG 
  Reverse TTA TTT TTT AAG GTT GTA GAA TGC TTT AAG 
L. plantarum: Forward ATG TCT ATT ATT ACA GAT ATT TAT GCT CGC 
Reverse TTA CTT GCT AGT AAT GGT GTT CCG T 
Forward ATG GAA AAA CAA GTT ATT GAA ACG G 
Reverse TTA GTC AAA CAT CAC GTT ATT TGG G 
For the E. coli, L. lactis, and both L. plantarum genes, a hot-start PCR was 
performed using a 5 minute denaturation at 98°C, followed by a pause to add polymerase, 
then thirty cycles with a 30 second denaturation at 98°C, 30 second annealing step at 
55°C, and a 2 minute extension step at 72°C.  Finally a 10 minute polishing step at 72°C 
was performed.  For the S. cerevisiae gene, the PCR cycling was similar, except that the 
annealing step was done at 53°C.  
 Following PCR, the fragments corresponding to the enolase genes were gel 
purified to remove excess primers, dNTPs, and PCR enzyme.  Fifty nanograms of 
purified DNA were used in a secondary PCR reaction to add the extensions necessary for 
ligation-independent cloning.  The primers were exactly as above, except with the 
addition of the following regions complementary to the pET30 LIC cloning region: 
 5’ GAC GAC GAC AAG 
 3’ GAG GAG AAG CCC GGT 
The PCR products with extensions were generated using the same cycling 
parameters as above, gel purified, and cloned into the pET30 vector following the 
procedures outlined in the product manual.  The vectors were transformed into the 
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BL21(DE3-RIL) expression strain.  Restriction digest was used to determine the presence 
of a correctly sized insert, and selected colonies were sequenced at the FAME sequencing 
center. 
6.2.3 Overexpression and Purification of the Enolase Enzymes 
Single colonies were inoculated into at 10 mL overnight seed culture and grown at 
37°C.  The next day, 100 µl of this culture was diluted into 500 mL of fresh medium with 
30 µg/mL kanamycin.  The cells were grown until the optical density at 600 nm reached 
0.5, and then induced with IPTG to a final concentration of 0.2 mM.  The culture was 
incubated for an additional 4 hours at 37 °C to allow for protein production and then 
harvested by centrifugation and frozen overnight at -20°C.   
The following day, cells were lysed via sonication, and the enolase protein was 
purified using the Talon Metal Affinity resin.  The resin was used primarily according to 
manufacturer’s instructions, except that 50 mM HEPES was used in place of 50 mM 
phosphate due to the potential metal chelating effects of phosphate and the knowledge 
that enolase requires the presence of magnesium ions.  The protein lysate, unbound 
fraction, and eluate were analyzed via SDS-PAGE gel.   
6.2.4 Synthesis of N-acetyl-(R)-phenylglycine 
N-acetyl-(R)-phenylglycine (Figure 6.3) was synthesized by acetylating the amino group 
of (R)-phenylglycine.  1.51 grams of (R)-phenylglycine was added to 2 mL of 50:50 
(w/v) sodium hydroxide: water.  To this, 1 mL of acetic anhydride was added and the pH 
was adjusted to 6.5 to prevent chemical racemization of the product.  The solution was 
stirred until it became clear, approximately 3 hours.  Subsequently, 10 N HCl was added 
to adjust the pH to 1.5 and promote crystallization of the product.  The solution was 
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stirred an additional 1.5 hours to allow crystals to form.  The crystals were filtered, 
washed with water, and vacuum dried.  The optical rotation of a 0.5 g/ 100 mL solution in 









6.2.5 Activity Assays 
The eluted protein was assayed for enolase activity using a solution of 2 mM 
phosphoenolpyruvate in a buffer consisting of 50 mM imidazole, 10 mM magnesium 
sulfate, and 400 mM KCl, pH 8.0.  Various amounts of enzyme were added and the 
decrease in absorbance at 240 nm was monitored for the conversion of 
phosphoenolpyruvate. 
The activity of the enolases as a mandelate racemase was tested using a 13.1 mM 
solution of (S)-mandelic acid in 50 mM Tris-HCl pH 7.5.  Enzyme was added and the 
change in optical rotation at 589 nm was monitored.  The N-acetyl amino acid racemase 
activity was tested using a 50 mM solution of N-acetyl-(R)-phenylglycine in 50 mM Tris-
HCl pH 7.5.  The enzyme was added and the change in optical rotation at 589 nm was 
monitored.  
 
Figure 6.3:  N-acetyl-(R)-phenylglycine 
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6.3 Results 
6.3.1 Isolation of Enolase Genes 
The initial amplification of the enolase genes from genomic DNA is shown in Figure 
6.4.  In all five cases, there is a single product band, of approximately correct size.  The 
cloning into pET30 was successful and the sequencing results are listed in Table 6.1.  In 
each case, there was at least one mutation; however, none of these were in residues 










Figure 6.4:  Initial amplification of the enolase genes 
LEFT:  Lane 1- Ladder, Lane 2- S. cerevisiae enolase 
RIGHT Lane 1- Ladder, Lane 2- E. coli enolase, Lane 3- L. lactis 
enolase, Lane 4- L. plantarum 1 enolase, Lane 5- L. plantarum 2 
enolase 
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Table 6.1: Summary of mutations in the various enolase enzymes: 
 
S. cerevisiae  S188F 
E. coli   D255G 
L. lactis  I74T 
L. plantarum 1 A306T 
L. plantarum 2 S200T, M221I 
 
 
6.3.2 Enolase Overexpression and Purification 
The SDS-PAGE results for the overexpression of the E. coli and S. cerevisiae 
enolases are shown in Figure 6.5.  Both of these expressed well and were purified to near 





Figure 6.5:  Expression of S. cerevisiae and E. coli enolases 
Lane 1- E. coli lysate, Lane 2- E. coli unbound fraction, Lane 3- purified E. coli 
enolase, Lane 4- E. coli insoluble fraction, Lane 5- Ladder, Lane 6- purified S. 
cerevisiae enolase, Lane 7- purified S. cerevisiae unbound fraction, Lane 8- S. 
cerevisiae lysate, Lane 9- S. cerevisiae insoluble fraction, Lane 10- purified S. 
cerevisiae enolase 
1 2 3 4 5 6 7 8 9 10
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The SDS-PAGE results for the overexpression of enoA from L. lactis are shown in 
Figure 6.6.  Here, the expression level in the soluble fraction is very low and the amount 
of purified protein obtained was also much lower than with E. coli or S. cerevisiae.  The 
purity also seems to be much lower as indicated by the presence of additional bands with 





Finally, the SDS-PAGE results for the overexpression of both enolases from L. 
plantarum are shown in Figure 6.7.  In neither case is a visible amount of purified protein 
obtained, despite measurable amounts of protein detected in the Bradford assay (165 
Figure 6.6: Expression of L. lactis enolase 
Lane 1- Insoluble Fraction, Lane 2- Lysate, Lane 3- Unbound, Lanes 4 and 5 - 
purified L. lactis enolase 
 
1 2 3 4 5
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µg/mL for LP1 and 200 µg/mL for LP2).  This indicates non-specific binding of various 





6.3.3 N-acetyl-D-phenylglycine Synthesis 
H1 and C13 NMR synthesized N-acetyl-(R)-phenylglycine were consistent with 
successful synthesis of the desired product.  The optical rotation of a 0.5 g/ 100 mL 
solution in room temperature distilled water at 589 nm was -0.6429, which corresponds 
to a specific molar rotation of -128.64°.  The published value for the molar rotation under 
the same conditions is -197°,23 indicating that the sample is about 34% racemized. 
 
Figure 6.7:  Expression of Lactobacillus plantarum enolases 
Lane 1- L. plantarum 1 insoluble fraction, Lane 2- L. plantarum 1 lysate, Lane 3- L. 
plantarum 1 unbound fraction, Lane 4- purified L. plantarum 1, Lane 5- Ladder, 
Lane 6- L. plantarum 2 insoluble fraction, Lane 7- L. plantarum 2 lysate, Lane 8- L. 
plantarum 2 unbound fraction, Lane 9- purified L. plantarum 2.  
1 2 3 4 5 6 7 8 9
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6.3.4 Activity Assays 
The equilibrium of the enolase reaction lies toward the conversion of 2-
phosphoglyceric acid to phosphoenolpyruvate.  Therefore, reaction of 
phosphoenolpyruvate to 2-phosphoglyceric acid does not go to completion.  This 
complicates the calculation of specific activity and characterization of the enzyme under 
different conditions because a minimal decrease in absorbance at 240 nm is seen before 
equilibrium is achieved.  Therefore, measurements of enolase activity on the proteins 
(Table 6.2) are only classified as ‘active’ (i.e. decrease in absorbance) or ‘inactive’ (i.e. 
no decrease in absorbance).  The enolases from E. coli, S. cerevisiae, and L. lactis were 
all active, whereas the two enzymes from L. plantarum did not show any activity.  None 
of the enolases in this study showed the ability to racemize mandelic acid or N-acetyl-D-
phenylglycine under the conditions of measurement.   
 






N-acetyl amino acid 
racemase activity 
E. coli active not active not active 
S. cerevisiae active not active not active 
L. lactis active not active not active 
L.plantarum 1 not active not active not active 
L. plantarum 2 not active not active not active 
 
6.4 Discussion 
The enolases from E. coli, S. cerevisiae, and L. lactis were successfully cloned 
and overexpressed in E. coli BL21(DE3-RIL).  All three were active as enolases, but not 
active towards mandelic acid or N-acetyl-D-phenylglycine.  Neither of the putative 
enolase genes from L. plantarum overexpressed adequately in the soluble, nor did the 
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purified fraction show activity towards phosphoenolpyruvate, mandelic acid, or N-acetyl-
D-phenylglycine.  The only report on the L. plantarum enzymes in the literature is a 
patent application which reports evidence that they may be partially transported to the 
cellular membrane and exposed extracellularly.21  In order to be exposed to the 
extracellular environment, the enolase would have to be at least partially inserted into the 
cellular membrane.  To accomplish this, special hydrophobic domains would be 
necessary and these may cause aggregation when the protein is being overexpressed, 
causing a lack of soluble expression.  Use of the freeware program SignalP to evaluate 
the likelihood of a signal sequence that could be used for such translocation and insertion, 
however, detected no evidence of a signal sequence.24    
The substrate N-acetyl-D-phenylglycine was successfully synthesized.  Although 
the product is predicted to be 34 % racemized based on comparison to the literature value 
for the molar optical rotation, the rotation is sufficient for the compound to be used in 
assays for N-acetyl amino acid racemase activity without further purification, since it has 
sufficient optical rotation. 
In summary, three potential α/β-barrel scaffolds, the enolases from E. coli, S. 
cerevisiae, and L. lactis were successfully cloned, overexpressed, and their enolase 
activity verified by assay with phosphoenolpyruvate.  These scaffolds can now be used 
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CONCLUSIONS AND FUTURE WORK 
 
 
The widespread adoption of biocatalytic processes is currently hampered by long 
development times for biocatalysts with novel and sufficient activity and adequate 
stability under operating conditions.  Protein engineering, while extremely useful for 
modifying the properties of protein catalysts in select cases, still cannot be performed 
rapidly enough for many applications.  The work presented herein seeks to increase the 
efficiency of protein engineering experiments and decrease the time necessary to develop 
novel biocatalysts.   
Protein engineering involves two steps:  the generation of diversity and the 
screening or selection of variants with the desired properties.  Chapter VI outlines 
preliminary work on the diversity generation step, attempting to create a smaller, more 
manageable number of mutants, but with a larger likelihood of improved activity for any 
given mutant.  Chapters III through V are concerned with decreasing the time investment 
in the screening process. 
This work represents a foundation for a number of subsequent experiments.  In 
Chapters III and IV, we have shown that the use of pooling increases the sample size that 
can be screened, and as a consequence, increases the number of improved mutants that 
will be identified.  The Monte-Carlo simulation model of pooling can be used to test 
several pooling strategies in silico to determine which experimental protocol is best for a 
given system.  Given that screening experiments represent a significant time investment, 
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while computational results can be generated for a number of scenarios rather quickly, 
the use of the model is expected to save a significant amount of time and effort in the 
laboratory.  Pooling is most suited to experimental systems where the average level of 
background is low, such as in the evolution of a completely new activity, or with a 
diversity generation protocol that create a high percentage of inactive mutants.  
One particular type of experiment for which pooling might be useful is the 
evolution of mutants with very highly increased thermostability.  Much of the literature in 
this area suggests that gains in thermostability come largely from the additive 
contributions of several interactions that have small impact on their own.  One can 
envision a strategy whereby mutants containing single, beneficial mutations identified by 
error-prone PCR or similar methods are recombined and screened using pooling at a very 
high temperature cut-off.  The background level of activity in this situation would be 
negligible, and only the very rarely occurring recombinants that received most of the 
beneficial mutations would survive.  This strategy could rapidly identify very highly 
thermostable mutants. 
Additionally, the concept of pooling could be expanded to include the creation of 
pools at the transformation step using electroporation.  Theoretically, each cell in the 
transformation mixture can take up more than one plasmid, and although these plasmids 
might segregate into different daughter cells, each colony grown on an agar plate would 
then represent a hetereogeneous population containing variants with different activity 
levels, essentially an artificially constructed pool.  To utilize our Monte-Carlo model we 
would need to estimate the pooling level of each colony (e.g. how many different variants 
are represented in each colony).  There are several models of DNA uptake by 
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electroporation, both empirical1 and computational2 which could be integrated into the 
simulation to determine how many plasmids will enter into each cell on average.  To 
determine the number of different variants that would be included, the activity 
distribution would be applied to determine the probability of a given number of unique 
plasmids entering the cell.  The external DNA concentration, the pulse time of the electric 
field, and the voltage applied could be used to tune the number of variants per pool.  In 
this scheme, each colony on an agar plate would actually represent a hetereogenous 
population, or a pool that could be assayed individually.  These colonies could be directly 
picked to a multi-well plate, creating one fewer step in the experimental protocol.  
Alternatively, such a system would allow the extension of the pooling model to filter lift 
assays of the colonies directly after transformation. 
 Chapter V discusses the creation of a series of cloning vectors to express the 
variant proteins.  The current vectors were constructed in additive fashion, so the 
intermediates are available for use as well as the final vector which contains a 
tetracycline-based promoter/operator, triclosan resistance, a ligation-independent cloning 
site, and a monomeric red fluorescent protein reporter (mRFP).  We attempted to 
construct an intein-mediated fusion of the mRFP expression reporter to our gene of 
interest so that it would be present in stoichometric amounts, however this did not fold 
correctly.   A recent paper by Tsien suggests that the problem may be due to a low 
tolerance to fusion proteins by mRFP, which could potentially be improved by changing 
the termini of the protein to be more similar to GFP.3  This should be the first future 
experiment and could be done combinatorially with fast and efficient selection for fusion-
tolerant mRFP genes by fluorescence activated cell sorting.4   
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 Chapter VI outlines the cloning, overexpression, and basic activity assay of the 
α/β-barrel enzyme enolase for use as a scaffold for the evolution of new function.  α/β-
barrel enzymes represent an efficient scaffold since a large portion of the residues are 
responsible for maintaining the secondary structure elements and do not participate in 
binding of the substrate or catalysis.  In addition, the loop residues responsible for 
structure are separate from the residues, which are responsible for stability.  Thus, with 
only mutations targeted to one portion of the enzyme, new functions can be evolved.   
 α/β-barrel enzymes participate in reactions in nearly all of the enzyme classes, so 
any chemistry is compatible with the fold.  To test the feasibility of the α/β-barrel as a 
scaffold, the first evolution targets should be chosen from the same superfamily as 
enolase.  Closely related functions include the ortho-succinyl benzoate synthase, N-acetyl 
amino acid racemase, muconate lactonizing enzyme, glucarate dehydratase, and 
mandelate racemase.5  The ortho-succinyl benzoate synthase activity is 
thermodynamically much easier than the other reactions since the pKa of the hydrogen 
that is abstracted is only approximately 8, while the other reactions involve abstraction of 
a hydrogen atom that has a much higher pKa (15 and higher).  However, this substrate 
must be synthesized enzymatically, which could prove very difficult.  In addition, the 
pKa of the alpha hydrogen of 2-phosphoglyceric acid (the substrate of enolase) is greater 
than 30,6 and the enzyme is still able to abstract it, so this bears less consideration than 
the ease of assay and/or a selection method for identification of active mutants.  Thus, 
mandelate racemase should be the first target as its activity can be selected for (using the 
ability of Pseudomonas aeruginosa to grow on S-mandelate as a sole carbon source as in 
the identification of the gene for the enzyme originally,7 and the substrate has a high 
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optical rotation, making it ideal for polarimeteric assays.  Another potential set of targets 
should include other reactions that are thermodynamically easy to accomplish, such as 
hydrolyses.  Since it is known which residues are responsible for binding the current 
substrate in enolase, and the structures of the E. coli and S. cerevisiae structures have 
been solved, structure guided determination areas to select for mutation should be 
explored for further refinement of residues to target.  Another potential tool in choosing 
which areas of the protein to mutate would be to dock the targeted substrate into the 
crystal structure.  Docking may also help determine which residues to target to change 
the active site chemistry as well.       
The work presented here is a foundation for many future protein engineering 
projects.  These tools should help to shorten the process of improving existing functions, 
and evolving new ones, increasing the applicability of biocatalysts to reactions which are 
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The executable command to run a pooling experiment is: 
 
javac -classpath . *.java 






 * Interface ActivityDistribution 
 * 
 * This interface forces any implementing class to  
 * provide a function called getActivity() that simulates 
 * the sampling of a random activity from a population. 
 * 
 * @author <a href="mailto:cspencer@cc.gatech.edu">Cody Spencer</a> 
 */ 
public interface ActivityDistribution { 
 
    /** 
     * Simulates the sampling of a random activity 
     * from a population. 
     * 
     * @return A random activity value 
     */ 










 * Class ActivityFunction 
 * 
 * Represents an activity distribution function with  
 * seven defining parameters. 
 * 
 * The activity value is generated by the following function: 
 * f(x) = y + a*e^(-b*x) + c*e^(-d*x) + g*e^(-h*x) where 
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 * y, a, b, c, d, g, and h are the set function parameters, 
 * e is the exponential number (~2.71), and 
 * x is a uniformly distributed random variable. 
 * 
 * @author <a href="mailto:cspencer@cc.gatech.edu">Cody Spencer</a> 
 */ 
public class ActivityFunction implements ActivityDistribution{ 
 
    /* Function parameters */ 
    private double y; 
    private double a; 
    private double b; 
    private double c; 
    private double d; 
    private double g; 
    private double h; 
 
    /** 
     * Class constructor for ActivityFunction. 
     * 
     * @param params The initial activity funciton parameters. 
     */ 
    public ActivityFunction(double[] params){ 
 setParams(params); 
    }//ActivityFunction(double[]) 
   
    /** 
     * Modifier for the parameters to the  
     * activity distribution function. 
     * 
     *@param params The array of parameters that 
     *              define this activity function. 
     */ 
    public void setParams(double[] params){ 
 y = params[0]; 
 a = params[1]; 
 b = -1.0 * params[2]; 
 c = params[3]; 
 d = -1.0 * params[4]; 
 g = params[5]; 
 h = -1.0 * params[6]; 
    }//setParams(double[]) 
 
 
    /** 
     * Simulates the sampling of an activity from this activity 
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     * distribution function with set parameters. 
     * 
     * @return A non-negative value representing a  
     *         sampled activity level. 
     */ 
    public double getActivity(){ 
 double x = Uniform.staticNextDouble(); 
 double toReturn = y+ a*Math.exp(b*x)+ c*Math.exp(d*x)+ g*Math.exp(h*x); 
  
 if(toReturn < 0.0) 
     return 0.0; 
 
 return toReturn; 










 * Class ActivityHistogram 
 * 
 * An ActivityHistogram represents the distribution of possible values 
 * that the activity level could be in a population. 
 * 
 * @author <a href="mailto:cspencer@cc.gatech.edu">Cody Spencer</a> 
 */ 
public class ActivityHistogram implements ActivityDistribution { 
 
    /** 
     * An array representing this values in this histogram. 
     */ 
    private double[] histo; 
 
    /** 
     * Class constructor for ActivityHistogram. 
     * 
     * @param h An array representing this values in this histogram. 
     */ 
    public ActivityHistogram(double[] h){ 
 histo = h; 
    }//ActivityHistogram(double[]) 
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    /** 
     * Simulates the sampling of a random activity from this  
     * activity distribution histogram. 
     * 
     * @return A non-negative value representing a  
     *         sampled activity level. 
     */ 
    public double getActivity(){ 
 int index = (int)(Uniform.staticNextDouble() * histo.length); 
 return histo[index]; 








public class BinDistribution implements ActivityDistribution{ 
 
     
    private double[] percents; 
    private double[] activities; 
 
    public BinDistribution(double[] percents, double[] activities){ 
 this.percents = percents; 
 this.activities = activities; 
 normalize(); 
    }//BinDistribution(double[],double[]) 
     
    private void normalize(){ 
 double sum = 0.0; 
 for(int i=0; i < percents.length; i++){ 
     sum += percents[i]; 
 } 
 for(int j=0; j < percents.length; j++){ 
     percents[j] = percents[j] / sum; 
 } 
    }//normalize() 
 
    public double getActivity(){ 
 int bin = 0; 
 double temp = percents[0]; 
 double rand = Uniform.staticNextDouble(); 
 int max_size = percents.length - 1; 
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 while((rand > temp) && (bin < max_size)){ 
     bin++; 
     temp += percents[bin]; 
 }//while 
 
 return activities[bin]; 
 
    }//getActivity() 
 
    public String toString(){ 
 String strToReturn = "BinDistribution  "; 
 strToReturn += "[ACTIVITY,%]\n"; 
 for(int i=0; i < percents.length; i++){ 
     strToReturn += "[" + activities[i] + "," + percents[i] + "]\n"; 
 } 
 return strToReturn; 









 * Cell.java 
 * 
 * For use in the Directed Evolution Project. 
 * 
 * This class simulates sequences of bases that are composed into the DNA 
 * of Cells and defines operations on such sequences, like mutatgenesis. 
 * 
 * Created: Mon Sep 02 03:16:50 2002 
 * 
 * @author <a href="mailto:rjojr@cc.gatech.edu">Jim Ogilvie</a> 
 * @version 1.0 
 */ 
public class Cell { 
 
    
/*==============================================================
==*/ 
    /*              I N S T A N C E   V A R I A B L E S               */ 





    /** 
     * Instance variable denoting the base sequence of this Cell's DNA 
     */ 
    private char[] bases; 
 
    /** 
     * A value indicating the activity of this Cell 
     */ 
    private double activity; 
 
    /** 
     * A value indicating the stability of this Cell 
     */ 
    private double stability; 
 
    /** 
     * Is this cell a supermutant or dud? 
     */ 
    private boolean supermutant; 
 
    
/*==============================================================
==*/ 
    /*                S T A T I C   V A R I A B L E S                 */ 





    /** 
     * Constant <code>BASE_A_INDEX</code> represents the   
     * int used to index the base A in arrays. 
     */ 
    public static final int BASE_A_INDEX = 0; 
 
    /** 
     * Constant <code>BASE_C_INDEX</code> represents the   
     * int used to index the base C in arrays. 
     */ 
    public static final int BASE_C_INDEX = 1; 
 
    /** 
     * Constant <code>BASE_G_INDEX</code> represents the   
     * int used to index the base G in arrays. 
     */ 
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    public static final int BASE_G_INDEX = 2; 
 
     /** 
     * Constant <code>BASE_T_INDEX</code> represents the   
     * int used to index the base T in arrays. 
     */ 
    public static final int BASE_T_INDEX = 3; 
 
    /** 
     * Constant <code>BASE_A_CHAR</code> is the  
     * char representation of the base A. 
     */ 
    public static final char BASE_A_CHAR = 'a'; 
 
    /** 
     * Constant <code>BASE_C_CHAR</code> is the  
     * char representation of the base C. 
     */ 
    public static final char BASE_C_CHAR = 'c'; 
 
    /** 
     * Constant <code>BASE_G_CHAR</code> is the  
     * char representation of the base G. 
     */ 
    public static final char BASE_G_CHAR = 'g'; 
 
    /** 
     * Constant <code>BASE_T_CHAR</code> is the  
     * char representation of the base T. 
     */ 
    public static final char BASE_T_CHAR = 't'; 
 
 
    /** 
     * <code>BASE_CHARS</code> is a constant array containing BASE_X_CHAR  
     * at index BASE_X_INDEX for all four bases, A,C,G,and T. 
     */ 
    public static final char[] BASE_CHARS = { BASE_A_CHAR, BASE_C_CHAR,  
           BASE_G_CHAR, BASE_T_CHAR }; 
 
    /** 
     * Standard, default constant distribution  
     * used to generate random gene sequences. 
     */ 
    public static final double[] DEFAULT_FREQ = {0.25, 0.25, 0.25, 0.25}; 
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    /** 
     * Another constant used in generating random gene sequences -  
     * this value specifies the length of the random sequence. 
     */ 
    public static final int DEFAULT_GENE_LENGTH = 60; 
 
    /** 
     * Default file to look in for mutation rates among bases 
     */ 




    
/*==============================================================
==*/ 
    /*                    C O N S T R U C T O R S                     */ 





    /** 
     * Creates a new <code>Cell</code> instance given the bases. 
     * 
     * @param bases a <code>char[]</code> value specifying the base  
     *              sequence for this Cell - this array should only  
     *              contain the ASCII characters 'a', 'c', 'g', and 't'. 
     */ 
    public Cell(char[] bases){ 
 this.bases = bases; 
    } 
 
    /** 
     * Creates a new <code>Cell</code> instance from the default values. 
     */ 
    public Cell(){ 
 this(DEFAULT_GENE_LENGTH); 
    } 
 
    /** 
     * Creates a new <code>Cell</code> instance of given length,  
     * using the default distribution on bases. 
     * 
     * @param length a positive length(in number of bases) this Cell should be. 
     */ 
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    public Cell(int length){ 
 this(length, DEFAULT_FREQ); 
    } 
     
    /** 
     * Creates a new <code>Cell</code> instance of given activity.  
     * 
     * @param activity This Cell's activity level. 
     */ 
    public Cell(double activity){ 
 this.activity = activity; 
    } 
 
    public Cell(double activity, boolean sm){ 
 this.activity = activity; 
 supermutant = sm; 
    } 
 
    /** 
     * Creates a new <code>Cell</code> instance. 
     * 
     * @param length an <code>int</code> value 
     * @param frequency a <code>double[]</code> value 
     */ 
    public Cell(int length, double[] frequency){ 
 // making sure length is a multiple of 3 
 length = (length/3)*3; 
 
 if(length > 0) { 
     bases = new char[length]; 
 
     double rand = 0.0; 
     for(int i=0; i<length; i++) { 
  rand = Math.random(); 
 
  rand -= frequency[BASE_A_INDEX]; 
  if(rand < 0) { 
      bases[i] = BASE_A_CHAR; 
  } 
  else { 
      rand -= frequency[BASE_C_INDEX]; 
      if(rand < 0) { 
   bases[i] = BASE_C_CHAR; 
      } 
      else { 
   rand -= frequency[BASE_G_INDEX]; 
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   if(rand < 0) { 
       bases[i] = BASE_G_CHAR; 
   } 
   else { 
       rand -= frequency[BASE_T_INDEX]; 
       if(rand < 0) { 
    bases[i] = BASE_T_CHAR; 
       } 
       else { 
    // error! 
       } 
   } 
      } 
  } 
     } // for(i) 
 } // if(length > 0) 
 else { 
     // error 
 } 
 




    
/*==============================================================
==*/ 
    /*                  S T A T I C   M E T H O D S                   */ 





    /** 
     * Describe <code>doMutagenesis</code> method here. 
     * 
     * @param g a <code>Cell</code> value 
     * @return a <code>Cell</code> value 
     */ 
    public static Cell doMutagenesis(Cell g){ 
 return doMutagenesis(g, DEFAULT_MUTAGENESIS_FILE); 
    }//doMutagenesis(Cell) 
 
    /** 
     * Describe <code>doMutagenesis</code> method here. 
     * 
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     * @param g a <code>Cell</code> value 
     * @param filename a <code>String</code> value 
     * @return a <code>Cell</code> value 
     */ 
    public static Cell doMutagenesis(Cell g, String filename){ 
 BufferedReader br = null; 
 try { 
     br = new BufferedReader(new FileReader(filename)); 
 } 
 catch(IOException ioe) { 
     System.out.println("Error opening file: " + filename); 
 } 
 
 double[][] transitions = new double[4][4]; 
 
 try { 
     String line = br.readLine(); 
     int num = 0; 
     while(line != null) { 
  int index = line.indexOf(':'); 
  if(index >= 0) { 
      transitions[num/4][num%4] =  
   Double.parseDouble(line.substring(index+1)); 
      num++; 
  } 
  else { 
      throw new Exception("Invalid file format"); 
  } 
  line = br.readLine(); 
     } 
 } 
 catch(IOException ioe) { 
     System.out.println("Error reading file: " + filename); 
 } 
 catch(Exception e) { 
     System.out.println("Error parsing file: " + filename); 
     e.printStackTrace(); 
 } 
 
 return doMutagenesis(g, transitions); 
    }//doMutagenesis(Cell,String) 
 
 
    /** 
     * Describe <code>doMutagenesis</code> method here. 
     * 
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     * @param g a <code>Cell</code> value 
     * @param transitions a <code>double[][]</code> value 
     * @return a <code>Cell</code> value 
     */ 
    public static Cell doMutagenesis(Cell g, double[][] transitions){ 
 char[] bases = new char[g.getBases().length]; 
 for(int i=0; i<bases.length; i++) { 
     bases[i] = g.getBases()[i]; 
 } 
 
 for(int i=0; i<bases.length; i++) { 
     double rand = Math.random(); 
      
     int index = getIndexOf(bases[i]); 
 
     boolean done = false; 
     for(int j=0; j<transitions[index].length && !done; j++) { 
  rand -= transitions[index][j]; 
  if(rand < 0) { 
      bases[i] = BASE_CHARS[j]; 
      done = true; 
  } 




 return new Cell(bases); 
    }//doMutagenesis(Cell, double[][]) 
 
 
    public static final int numSpecialPositions = 8; 
    public static final double probPosGood = .25; 
 
    public static boolean evaluateLandscape(Cell g){ 
 // determine which positions are crucial to acticity,  
        // basically an easy attemp at simulating small worlds 
 int[] specPos = new int[numSpecialPositions]; 
 int index = 0; 
 while(index < numSpecialPositions) { 
     boolean done = true; 
     int newPos = (int) (Math.random()*DEFAULT_GENE_LENGTH/3); 
     for(int i=0; i<index; i++) 
  if(specPos[index] == newPos) 
      done = false; 
     if(done) 




 // setting up a matrix of good/bad values for each position  
        // as chosen above, using the specified probability 
 boolean[][] goodBad = new boolean[numSpecialPositions][20]; 
 for(int i=0; i<goodBad.length; i++) 
     for(int j=0; j<goodBad[i].length; j++) 
  if(Math.random() > probPosGood) 
      goodBad[i][j] = true; 
 
 int[] posEffects = new int[numSpecialPositions]; 
 for(int i=0; i<goodBad.length; i++) { 
     char[] codon = new char[3]; 
     codon[0] = g.getBases()[3*specPos[i]]; 
     codon[1] = g.getBases()[3*specPos[i]+1]; 
     codon[2] = g.getBases()[3*specPos[i]+2]; 
     int aa = AminoAcid.getAminoAcidFromBases(codon); 
     posEffects[i] += (goodBad[i][aa] ? 1 : -1); 
 } 
 
 int sumEffect = 0; 
 for(int i=0; i<posEffects.length; i++) { 





 if(sumEffect > 0) 
     return true; 
 else 
     return false; 
    }//evaluateLandscape(Cell) 
 
 
    /** 
     * Describe <code>getIndexOf</code> method here. 
     * 
     * @param c a <code>char</code> value 
     * @return an <code>int</code> value 
     */ 
    public static int getIndexOf(char c){ 
 int index = -1; 
     switch(c) { 
     case BASE_A_CHAR:  
  index = BASE_A_INDEX; 
  break; 
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     case BASE_C_CHAR: 
  index = BASE_C_INDEX; 
  break; 
 
     case BASE_G_CHAR: 
  index = BASE_G_INDEX; 
  break; 
 
     case BASE_T_CHAR: 
  index = BASE_T_INDEX; 
  break; 
     } 
     return index; 
    }//getIndexOf(char) 
 
    /** 
     * Describe <code>compare</code> method here. 
     * 
     * @param g a <code>Cell</code> value 
     * @param h a <code>Cell</code> value 
     */ 
    public static void compare(Cell g, Cell h){ 
 int[][] changes = new int[4][4]; 
 int num = Math.min(g.getBases().length, h.getBases().length); 
 for(int i=0; i<num; i++){ 
     changes[getIndexOf(g.getBases()[i])][getIndexOf(h.getBases()[i])]++; 
 } 
 
 double[] sums = new double[4]; 
 
 for(int i=0; i<changes.length; i++) { 
     for(int j=0; j<changes[i].length; j++) { 
  sums[i] += changes[i][j]; 
     } 
 } 
 
 for(int i=0; i<changes.length; i++) { 
     for(int j=0; j<changes[i].length; j++) { 
  System.out.println(BASE_CHARS[i] + " to " +  
       BASE_CHARS[j] + ": " + changes[i][j] + "\t " +  
       ((double)changes[i][j])/(sums[i])); 
     } 
 } 
      




    
/*==============================================================
==*/ 
    /*               I N S T A N C E   M E T H O D S                  */ 




    /** 
     * Describe <code>getBases</code> method here. 
     * 
     * @return a <code>char[]</code> value 
     */ 
    public char[] getBases(){ 
 return this.bases; 
    }//getBases() 
 
    /** 
     * Modifier for the activity field. 
     *  
     * @param d This Cell's activity level. 
     */ 
    public void setActivity(double d){  
 this.activity = d;  
    }//setActivity(double) 
     
    /** 
     * Accessor for the activity field. 
     *  
     * @return This Cell's activity level. 
     */ 
    public double getActivity(){ 
 return this.activity;  
    }//getActivity() 
  
    /** 
     * Is this cell a supermutant? 
     * 
     * @return true or false 
     */ 
    public boolean isSupermutant(){ 
 return this.supermutant; 
    }//isSupermutant() 
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    /** 
     * Describe <code>toString</code> method here. 
     * 
     * @return a <code>String</code> value 
     */ 
    public String toString(){ 
 String toRet = ""; 
 if(bases != null) 
     for(int i=0; i<bases.length; i++) 
  toRet += bases[i]; 
  
 return toRet; 
    }//toString() 
 
    /** 
     * Produces an exact copy of this Cell. 
     * 
     */ 
    public Cell copy(){ 
 Cell c = new Cell(this.getBases()); 
 c.setActivity(this.getActivity()); 
 return c; 
    }//copy() 
 
 
    
/*==============================================================
==*/ 
    /*                    M A I N   M E T H O D                       */ 





    /** 
     * Debug main method 
     * 
     * @param argv a <code>String[]</code> value 
     */ 
    public static void main(String[] argv){ 











 compare(g, h); 







 * Interface CellDistribution 
 * 
 * A CellDistribution is a way of representing how many cells 
 * are picked from a pool of many cells. 
 * 
 * @author <a href="mailto:cspencer@cc.gatech.edu">Cody Spencer</a> 
 */ 
public interface CellDistribution{ 
 
    /** 
     * Get the number of cells to use. 
     * 
     * @return number of cells 
     */ 









public class DBHelper{ 
 
    /*specifies how to connect to the database*/ 
    private static final String dbURL =  
 "jdbc:mysql://newcastle/epool?user=cody"; 
 
    /** 
     * See if the username and password match in the database. 
     * @param usr  username 
     * @param pass password 
     */ 
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    public static boolean validateUser(String usr, String pass){ 
  
 //resources 
 Connection conn = null; 
 Statement stmt = null; 
 ResultSet rs = null; 
 
  
 String dbpass = null;  // or use String dbpass = execSQL(query); 
 String sql_query = "select password from users where name like '" +  
     usr + "';"; 
  
 try { 
      
     //register the driver 
     Class.forName("org.gjt.mm.mysql.Driver").newInstance(); 
 
     //get a connection to the database 
     conn = DriverManager.getConnection(dbURL); 
     stmt = conn.createStatement(); 
     rs = stmt.executeQuery(sql_query); 
     dbpass = rs.getString(1); 
  
 } 
 catch(SQLException sqle){ 
     sqle.printStackTrace();      
 } 
 catch(Exception e){ 
     e.printStackTrace(); 
 } 
 finally{  //CLOSE ALL RESOURCES 
     try{ 
  if(stmt != null) 
      stmt.close(); 
     }catch(Exception e2){ 
  e2.printStackTrace(); 
     } 
     finally { 
  try{ 
      if(conn != null) 
   conn.close(); 
  }catch(Exception e3){ 
      e3.printStackTrace();  
  } 




 //is correct password? 
 if(pass.equalsIgnoreCase(dbpass)) 
     return true; 
  
 return false;  
    }//validateUser(String,String) 
 
 
    /** 
     * Executes a single SQL statement and returns relevant information. 
     */ 
    public static String execSQL(String sql_query){ 
 
 Connection conn = null; 
 Statement stmt = null; 
 ResultSet rs = null; 
 String toReturn = null; 
  
 try { 
      
     //register the driver 
     Class.forName("org.gjt.mm.mysql.Driver").newInstance(); 
 
     //get a connection to the database 
     conn = DriverManager.getConnection(dbURL); 
     stmt = conn.createStatement(); 
      
     if(sql_query == null){ 
  toReturn = null; 
     } 
     else{ 
  //parse query to determine action (query or update) 
  StringTokenizer st = new StringTokenizer(sql_query); 
  String temp = st.nextToken(); 
  if(temp.equalsIgnoreCase("select")){ 
      rs = stmt.executeQuery(sql_query); 
      toReturn = rs.getString(1); 
  } 
  else if(temp.equalsIgnoreCase("insert") || 
   temp.equalsIgnoreCase("update") || 
   temp.equalsIgnoreCase("delete")){ 
      int updatedRows = stmt.executeUpdate(sql_query); 
      toReturn = Integer.toString(updatedRows) +  
   " row(s) changed."; 
  } 
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  else 
      toReturn = null; 
     }//else 
 
 } 
 catch(SQLException sqle){ 
     sqle.printStackTrace();      
 } 
 catch(Exception e){ 
     e.printStackTrace(); 
 } 
 finally{  //CLOSE ALL RESOURCES 
     try{ 
  if(stmt != null) 
      stmt.close(); 
     }catch(Exception e2){ 
  e2.printStackTrace(); 
     } 
     finally { 
  try{ 
      if(conn != null) 
   conn.close(); 
  }catch(Exception e3){ 
      e3.printStackTrace();  
  } 
     }//finally 
 }//finally 
 
 return toReturn; 
 
    }//end execSQL(String, int) 
 
 
    /** 
     * Debugging main method. 
     */ 
    public static void main(String argv[]){ 
  
 String name = "test"; 













public class DiscreteDistribution implements ActivityDistribution{ 
     
    private static double val1 = 0.3125; 
    private static double val2 = 0.9375; 
    private double val3; 
    private double pMutant; 
 
    public DiscreteDistribution(double pMutant){ 
 if(pMutant > 1) 
     this.pMutant = 1; 
 else if (pMutant < 0) 
     this.pMutant = 0; 
 else 
     this.pMutant = pMutant; 
  
 val3 = (96.0 - pMutant) / 96.0; 
    } 
 
    public double getActivity(){ 
 double r = Math.random(); 
 if(r < val1) 
     return 0.0; 
 if(r < val2) 
     return 1.0; 
 if(r < val3){ 
     return 2.0; 
 } 
 else 
     return 15.0; 
    } 







 * Class ExpData 
 * 
 * A simple record class used to store the data from 
 * pooling experiments. 
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 * 
 *@see Experiment 
 *@author <a href="mailto:cspencer@cc.gatech.edu">Cody Spencer</a> 
 */ 
public class ExpData { 
 
    /** 
     * Whether or not the target was found. 
     */ 
    private boolean found; 
 
    /** 
     * The arithmetic mean value. 
     */ 
    private double mean; 
     
    /** 
     * The standard deviation. 
     */ 
    private double stdDev; 
     
    /** 
     * The minimum value. 
     */ 
    private double min; 
     
    /** 
     * The maximum value. 
     */  
    private double max; 
 
    private String printout; 
 
 
    /** 
     * Number of supermutants found. 
     */ 
    private int sm_found; 
 
    private int sm_false_pos; 
    private int sm_false_neg; 
 
    /** 
     * Class constructor specifying all four values. 
     * 
     * @param mean The arithmetic mean of the experimental data. 
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     * @param stdDev The standard deviation of the experimental data. 
     * @param min The minimum value of the experimental data.  
     * @param mean The maximum value of the experimental data. 
     */ 
    public ExpData(double mean, double stdDev, double min, double max, 
     String printout){ 
 this.mean = mean; 
 this.stdDev = stdDev; 
 this.min = min; 
 this.max = max; 
 this.printout = printout; 
    }//ExpData(double, double, double, double, String) 
 
    /** 
     * Class constructor for the case when we only care if the target  
     * was found or not. 
     * 
     * @param found If the target was found or not. 
     */ 
    public ExpData(boolean found){ 
 this.found = found; 
    }//ExpData(boolean) 
 
    /** 
     * Class constructor for the case when we only care  
     * how many supermutants were found. 
     * 
     * @param sm_found How many supermutants were found. 
     */ 
    public ExpData(int sm_found, String printout){ 
 this.sm_found = sm_found; 
 this.printout = printout; 
    }//ExpData(int) 
 
    /** 
     * Class constructor for the case when we only care  
     * how many supermutants were found and any false pos/neg 
     * 
     * @param sm_found How many supermutants were found. 
     * @param sm_false_pos Number of false positives 
     * @param sm_false_neg Number of false negatives 
     */ 
    public ExpData(int sm_found, int sm_false_pos, int sm_false_neg, 
     String printout){ 
 this.sm_found = sm_found; 
 this.sm_false_pos = sm_false_pos; 
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 this.sm_false_neg = sm_false_neg; 
 this.printout = printout; 
    }//ExpData(int,int,int,String) 
     
    /** 
     * Converts all four data values into a textual  
     * representation(a String). 
     * 
     * Overrides the default toString() method found in  
     * the Object class (java.lang.Object). 
     *  
     * @return A textual representation of this object. 
     */ 
    public String toString(){ 
 String toReturn = "Mean = " + Double.toString(mean) +  
     "\nStandard Deviation = " + Double.toString(stdDev) + 
     "\nMinimum = " + Double.toString(min) + 
     "\nMaximum = " + Double.toString(max); 
 return toReturn; 
    }//toString() 
 
    /** 
     * Accessor for the found variable. 
     * 
     * @return <code>true</code> if target was found,  
     * <code>false</code> if not. 
     */ 
    public boolean getFound(){ 
 return found; 
    }//getFound() 
 
    /** 
     * Accessor for the sm_false_pos value. 
     * 
     * @return The number of false positives found in this experiment. 
     */ 
    public int getSMFalsePos(){ 
 return sm_false_pos; 
    }//getSMFalsePos() 
 
    /** 
     * Accessor for the sm_false_neg value. 
     * 
     * @return The number of false negatives found in this experiment. 
     */ 
    public int getSMFalseNeg(){ 
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 return sm_false_neg; 
    }//getSMFalseNeg() 
 
 
    /** 
     * Accessor for the sm_found value. 
     * 
     * @return The number of supermutants found in this experiment. 
     */ 
    public int getSMFound(){ 
 return sm_found; 
    }//getSMFound() 
 
    /** 
     * Accessor for the minimum value. 
     * 
     * @return This experiment's minimum value.  
     */ 
    public double getMin(){ 
 return min; 
    }//getMin() 
     
    /** 
     * Accessor for the maximum value. 
     * 
     * @return This experiment's maximum value.  
     */ 
    public double getMax(){ 
 return max; 
    }//getMax() 
 
    /** 
     * Accessor for the mean value. 
     * 
     * @return This experiment's mean value.  
     */ 
    public double getMean(){ 
 return mean; 
    }//getMean() 
 
    /** 
     * Accessor for the standard deviation value. 
     * 
     * @return This experiment's standard deviation. 
     */ 
    public double getStdDev(){ 
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 return stdDev; 
    }//getStdDev() 
 
    public String getPrintout(){ 
 return printout; 
















 * Class Experiment 
 * 
 * The Experiment class represents a simulated lab experiment,  
 * generally used to simulate pooling experiments for Directed Evolution. 
 * 
 * @author <a href="mailto:cspencer@cc.gatech.edu">Cody Spencer</a> 
 */ 
public class Experiment { 
 
    /****************************************/ 
    /********* INSTANCE VARIABLES ***********/ 
    /****************************************/ 
 
    /** 
     * Activity Ratio being used.   
     *  
     * NOTE - This needs to be implemented better. 
     */ 
    private int AR;  
 
    private double MIN_ACT; 
 
    /** 
     * Oversampling ratio being used. 
     *  
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     * 1.0 means no oversampling. 
     */ 
    private double OR = 1.0; 
 
    /** 
     * Average number of cells expected to be in each well. 
     */ 
    private int mean_cells; 
 
    /** 
     * Percent of wells to evaluate using std data analysis. 
     */ 
    private double top_pct; 
 
    /** 
     * CV of assay being used. 
     */ 
    private double CV; 
 
    /** 
     * Represents which activity distribution the cells are  
     * being sampled from. 
     *  
     * Ex: SuperMutant distribution of cell activity. 
     */ 
    private ActivityDistribution ad; 
 
    /** 
     * Represents which cell distribution the cells are  
     * being sampled from. 
     * 
     * Ex: Poisson distribution of cells. 
     */ 
    private CellDistribution cell_dist; 
 
    /** 
     * Uncertainty 1: Poisson of cells/well (stage 1 & 2) 
     */ 
    private boolean u_type1 = true; 
     
    /** 
     * Uncertainty 2: Gaussian of assay error. 
     */ 
    private boolean u_type2 = true; 
     
    /** 
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     * Uncertainty 3: Multinomial distribution of cell sampling. 
     */ 
    private boolean u_type3 = true; 
     
    /** 
     * SuperMutant evaluation or not. 
     */ 
    private boolean SMeval; 
 
    private boolean GTeval; 
 
    private boolean print_all; 
 
 
    /****************************************/ 
    /*********** CONSTRUCTORS ***************/ 
    /****************************************/ 
     
    /* No need for specific constructors yet */ 
    /* Perhaps sub-class for supermutant vs normal evaluation? */ 
 
     
    /****************************************/ 
    /********** INSTANCE METHODS ************/ 
    /****************************************/ 
     
    /** 
     * Simulates the running of a Directed Evolution  
     * Experiment without using pooling (1 cell/well). 
     * Since there is only one stage (no need for a resolution stage),  
     * all of the wells are used in the first stage. 
     *  
     * @param total_wells Number of wells to use for this Experiment. 
     * @return The desired data reaped from this Experiment. 
     */ 
    public ExpData run_exp_no_pool(int total_wells){ 
 
 /*cells per drop, random over poisson distribution*/  
 int cells_per_well = 1; 
 
 Well[] wells = new Well[total_wells]; 
  
 /*Sample the cells from the broth into the wells*/ 
 for(int i = 0; i < total_wells; i++){ 
      
     if(u_type1){ 
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  cells_per_well = cell_dist.sample(); 
     } 
     wells[i] = new Well(cells_per_well); 
      
     //sample cells into wells 
     for(int j=0; j < cells_per_well; j++){ 
  double ddd = ad.getActivity(); 
  if(SMeval){ 
      if(ddd >= AR) 
   wells[i].setValue(j, new Cell(ddd,true)); 
      else 
   wells[i].setValue(j, new Cell(ddd,false)); 
  } 
  else 
      wells[i].setValue(j, new Cell(ddd)); 
 
     }//for(j) 
     if(u_type2){ 
  wells[i].assay(CV); 
     } 
     else{ 
  wells[i].assay(0.0); 
     } 
 }//for(i) 
  
 /*sort the wells by assayed activity level*/ 




 /* SUPERMUTANT ANALYSIS OF DATA */ 
 if(SMeval) 
     return sm_data_analysis(wells, 1); 
 else if(GTeval) 
     return greater_than_analysis(wells); 
 else 
     return std_data_analysis(wells); 
 
    }//run_exp_no_pool(int) 
 
 
    /** 
     * Simulates the running of a Directed Evolution  
     * Experiment using pooling (more than 1 cell/well). 
     *  
     * @param stg1_wells Number of wells to use for the first stage. 
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     * @param stg2_wells Number of wells to use for the second stage. 
     * @return The desired data reaped from this Experiment. 
     */ 
    public ExpData run_exp(int stg1_wells, int stg2_wells){ 
 return exp_stage1(stg1_wells,stg2_wells); 
    }//run_exp(int,int) 
 
    /** 
     * Pooling stage. 
     * 
     * @param stg1_wells Number of wells to use for the first stage. 
     * @param stg2_wells Number of wells to use for the second stage. 
     * @return The desired data reaped from this Experiment. 
     */ 
    private ExpData exp_stage1(int stg1_wells, int stg2_wells){ 
  
 /*desired cells per drop*/  
 int cells_per_well = mean_cells; 
 
 Well[] stage1 = new Well[stg1_wells]; 
 Well[] stage2 = new Well[stg2_wells]; 
  
 /*SAMPLING STAGE (stage1)*/ 
 for(int i = 0; i < stg1_wells; i++){ 
      
     /*Uncertainty of cell distribution*/ 
     if(u_type1){  
  cells_per_well = cell_dist.sample(); 
     } 
      
     /*create Well that holds specified # of cells*/ 
     stage1[i] = new Well(cells_per_well); 
      
     //sample cells into wells 
     for(int j=0; j < cells_per_well; j++){ 
  double ddd = ad.getActivity(); 
  if(SMeval){ 
      if(ddd >= AR) 
   stage1[i].setValue(j, new Cell(ddd,true)); 
      else 
   stage1[i].setValue(j, new Cell(ddd,false)); 
  } 
  else 
      stage1[i].setValue(j, new Cell(ddd)); 
     }//for(j) 
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     /*How to assay*/ 
     if(u_type2){ 
  stage1[i].assay(CV); 
     } 
     else{ 
  stage1[i].assay(0.0); 




 /*If using the two-stage approach, uncomment line below*/ 
 return exp_stage2(stage1, stage2, mean_cells); 
 
 /*If using the two-stage approach, comment-out line below*/ 
 //return sm_data_analysis(stage1, mean_cells); 
    }//exp_stage1(int,int) 
 
 
    /** 
     * Resolution stage of DE. 
     * 
     * @param stage1 Wells from stage 1. 
     * @param stage2 Wells used in resolution stage (already allocated). 
     * @param mean_cells Average cells per well in stage 1. 
     * @return The desired data reaped from this Experiment. 
     */ 
    private ExpData exp_stage2(Well[] stage1, Well[] stage2, int mean_cells){ 
 
 /*sort the wells in stage1 by assayed activity level*/ 
 /*Uses merge-sort O(n*log(n))*/ 
 Arrays.sort(stage1); 
  
 /*variables to keep track of which wells have been sampled*/ 
 int cell_num = 0; 
 int well_num = stage1.length - 1; 
 int oversamples = (int)(mean_cells * OR);//how much to oversample 
 
 /*RESOLUTION STAGE (stage2)*/ 
 
 for(int k = 0; k < stage2.length; k++){ 
      
     if(cell_num == oversamples){ 
   well_num --; 
   cell_num = 0; 
     }//if 
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     if(well_num < 0) 
  well_num = stage1.length - 1; 
 
     //sample 
     int samples = 1; 
     if(u_type1){ 
   samples = Poisson.staticNextInt(1.0); 
     }//if 
      
     stage2[k] = new Well(samples); 
      
     for(int r=0; r < samples; r++){ 
  if(u_type3) 
      stage2[k].setValue(r, stage1[well_num].sampleCell()); 
   else 
       stage2[k].setValue(r, stage1[well_num].getCell(cell_num)); 
     }//for(r) 
      
     if(u_type2){ 
   stage2[k].assay(CV); 
     } 
     else{ 
  stage2[k].assay(0.0); 
     } 
      
     cell_num++; 
 }//for(k) 
 
 /* ANALYZE DATA */ 
 if(SMeval) 
     return sm_data_analysis(stage2, mean_cells); 
 else if(GTeval) 
     return greater_than_analysis(stage2); 
 else 
     return std_data_analysis(stage2); 
    }//exp_stage2(Well[],Well[],int) 
 
 
    /** 
     * Standard Analysis of top 3% of wells.   
     * Mean, Std Dev, High and Low. 
     * 
     * @param wells The wells to analyze. 
     * @return Mean, Std. Dev, High and Low of best 3% of wells. 
     */ 
    private ExpData std_data_analysis(Well[] wells){ 
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 String well_print = null; 
 if(print_all) 
     well_print = "WELL ACTIVITIES\n-----------\n"; 
 
 /*sort the wells in stage2 by assayed activity level*/ 
 Arrays.sort(wells); 
 
 /*get the top 3% of cells*/ 
 int top_cells = (int)(0.01*top_pct*wells.length); 
 double top[] = new double[top_cells]; 
 for(int q = 0; q < top.length; q++){ 
     top[q] = wells[(wells.length - q) - 1].getActivity(); 
     if(print_all){ 
  well_print += MathHelper.formatDouble(top[q],3) + ",  "; 
  if((q%10)==9) 
      well_print += "\n"; 




 /* Analyze data */ 
 double dmean = MathHelper.mean(top); 
 double stdev = MathHelper.standardDeviation(top, dmean); 
 return new ExpData(dmean, stdev, top[top.length-1], top[0],  
      well_print);  
    }//std_data_analyis(Well[]) 
 
 
    private ExpData greater_than_analysis(Well[] wells){ 
 int num_found = 0; 
 int false_pos = 0; 
 int false_neg = 0; 
 Well w = null; 
 String well_print = null; 
 
 if(print_all) 
     well_print = "WELL ACTIVITIES\n-----------\n"; 
  
 for(int i=0; i < wells.length; i++){ 
     w = wells[i]; 
     if(w.getActivity() >= MIN_ACT){ 
  num_found++; 
  if(w.getRealActivity() < MIN_ACT) 
      false_pos++; 
     } 
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     else if(w.getRealActivity() >= MIN_ACT){ 
  false_neg++; 
     } 
      
     if(print_all){ 
  well_print += MathHelper.formatDouble(w.getActivity(),3) +  
      ",  "; 
  if((i%10)==9) 
      well_print += "\n"; 
     } 
 }//for(i) 
  
 return new ExpData(num_found, false_pos, false_neg, well_print); 
    }//greater_than_analysis(Well[]) 
 
    /** 
     * Supermutant Analysis 
     * 
     * @param wells The wells to analzye. 
     * @param mean_cells Average cells per well in stage 1. 
     * @return Number of SuperMutants found in wells. 
     */ 
    private ExpData sm_data_analysis(Well[] wells, int mean_cells){ 
 int num_found = 0; 
 int false_pos = 0; 
 int false_neg = 0; 
 String well_print = null; 
 if(print_all) 
     well_print = "WELL ACTIVITIES\n-----------\n"; 
 
 //May want to look at when AR < mean_cells 
 //double min_act = ((AR - 1)/mean_cells) + 1; 
 double min_act = AR * (1.0 - 3*CV); 
  
 Well w; 
 
 for(int i=0; i < wells.length; i++){ 
     w = wells[i]; 
      
     if(w.getActivity() >= min_act){ 
  num_found++; 
  if(!w.containsSupermutant()){ 
      false_pos++; 
      //System.out.println("Act: "+w.getRealActivity()); 
      //System.out.println("MAct:"+w.getActivity()); 
  } 
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     } 
     else{  
  if(w.containsSupermutant()){ 
      false_neg++; 
  } 
     } 
     if(print_all){ 
  well_print += MathHelper.formatDouble(w.getActivity(),3) +  
      ",  "; 
  if((i%10)==9) 
      well_print += "\n"; 
     } 
 }//for(i) 
 
 //System.out.println("MEM_MID=" + getMemoryKB()); 
  
 return new ExpData(num_found, false_pos, false_neg, well_print); 
    }//sm_data_analysis(Well[]) 
 
 
    /** 
     * Supermutant Analysis - find how many AR=2 at end 
     * 
     * @param wells The wells to analzye. 
     * @param mean_cells Average cells per well in stage 1. 
     * @return Number of SuperMutants found in wells. 
     */ 
    private ExpData sm2_data_analysis(Well[] wells, int mean_cells){ 
 
 int num_found = 0; 
 Well w; 
 Cell[] c; 
 
 for(int i=0; i < wells.length; i++){ 
     w = wells[i]; 
     c = w.getAllCells(); 
     if(c != null){ 
  for(int j=0; j < c.length; j++){ 
      if(c[j].getActivity() == 2.0) 
   num_found++; 
  }//for(j) 
     } 
 }//for(i) 
 return new ExpData(num_found, null); 




    /** 
     * Modifier method for the u_type1 field.  
     * 
     * @param on Whether or not to test this uncertainty type. 
     */ 
    public void setUTYPE1(boolean on){ 
 this.u_type1 = on; 
    } 
 
    /** 
     * Modifier method for the u_type2 field.  
     * 
     * @param on Whether or not to test this uncertainty type. 
     */ 
    public void setUTYPE2(boolean on){ 
 this.u_type2 = on; 
    } 
     
    /** 
     * Modifier method for the u_type3 field.  
     * 
     * @param on Whether or not to test this uncertainty type. 
     */ 
    public void setUTYPE3(boolean on){ 
 this.u_type3 = on; 
    } 
 
    /** 
     * Accessor method for the mean_cells field.  
     * 
     * @return The average number of cells per well. 
     */ 
    public int getMeanCells(){ 
 return mean_cells; 
    }//getMeanCells() 
 
    /** 
     * Modifier method for the mean_cells field.  
     * 
     * @param cells The average number of cells per well. 
     */ 
    public void setMeanCells(int cells){ 
 this.mean_cells = cells; 
    }//setMeanCells(int) 
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    /** 
     * Modifier method for the ad field. 
     * 
     * @param ad The new activity distribution to use for this Experiment. 
     */ 
    public void setActivityDistribution(ActivityDistribution ad){ 
 this.ad = ad; 
    }//setActivityDistribution(ActivityDistribution) 
 
    /** 
     * Modifier method for the cell_dist field. 
     * 
     * @param cd The new cell distribution to use for this Experiment. 
     */ 
    public void setCellDistribution(CellDistribution cd){ 
 cell_dist = cd; 
    }//setCellDistribution(CellDistribution) 
 
    /** 
     * Modifier method for the AR field. 
     * 
     * @param ratio The new activity ratio to use for this Experiment. 
     */ 
    public void setActivityRatio(int ratio){ 
 AR = ratio; 
    }//setActivityRatio(int) 
     
 
    public void setCV(double CV){ 
 this.CV = CV; 
    }//setCV(double) 
 
     
    public void setSMEval(boolean eval){ 
 this.SMeval = eval; 
    } 
 
    public void setTopPct(double top_pct){ 
 this.top_pct = top_pct; 
    } 
 
    public void setPrintAll(boolean printall){ 
 this.print_all = printall; 
    } 
 
    public void setGTeval(boolean eval){ 
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 this.GTeval = eval; 
    } 
 
    public void setMIN_ACT(double min_act){ 
 this.MIN_ACT = min_act; 
    } 
 
    /****************************************/ 
    /*********** CLASS METHODS **************/ 
    /****************************************/ 
       
    /** 
     * Runs multiple supermutant experiments with set parameters. 
     * Modify hard-coded numbers to set up your experiment. 
     * 
     * NOTE - Need to modulize this... interface?  
     */ 
    public static void run_main(ActivityDistribution ad, int act_ratio, 
    double assay_acc, double sm_ratio, 
    int num_plates, int plate_size, int cpw, 
    String output_file, int num_exps, 
    boolean sm_eval, double top_pct, 
    boolean print_all, boolean gt_eval, 
    double min_act){ 
 FileWriter fw = null; 
 PrintWriter pw = null; 
 
 int stg1_wells = num_plates*plate_size; 
 int stg2_wells = stg1_wells; 
 
 ExpData ed1 = null; 
 ExpData ed2 = null; 
  
 /*SUPERMUTANT DATA ANALYSIS*/ 
 double[] count_e1 = new double[num_exps]; 
 double[] count_e2 = new double[num_exps]; 
 double[] count_fp1 = new double[num_exps]; 
 double[] count_fp2 = new double[num_exps]; 
 double[] count_fn1 = new double[num_exps]; 
 double[] count_fn2 = new double[num_exps]; 
  
 /*STANDARD DATA ANALYSIS*/ 
 double[] mean_e1 = new double[num_exps]; 
 double[] sd_e1 = new double[num_exps]; 
 double[] max_e1 = new double[num_exps]; 
 double[] min_e1 = new double[num_exps]; 
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 double[] mean_e2 = new double[num_exps]; 
 double[] sd_e2 = new double[num_exps]; 
 double[] max_e2 = new double[num_exps]; 
 double[] min_e2 = new double[num_exps]; 
 String printout1 = null; 




 ActivityDistribution ad1; 
 CellDistribution cd1 = new PoissonDistribution(cpw); 















 try{  
     /*Open file and write header info*/ 
     fw = new FileWriter(output_file); 
     pw = new PrintWriter(fw); 
     pw.println(new Date().toString()); 
     pw.println(""); 
     pw.println(""); 
     pw.println("---------------------------------"); 
     pw.println("Assay CV = " + assay_acc); 
     pw.println("Mean Cells/Well = " + cpw); 
     pw.println("# plates per round = " + num_plates); 
     pw.println("# wells per plate = " + plate_size); 
     pw.println(ad.toString()); 
      
     for(int d=0; d < num_exps; d++){ 
  if(cpw==1){ 
      ed1 = e1.run_exp_no_pool(stg1_wells+stg2_wells); 
      ed2 = e1.run_exp_no_pool(stg1_wells+stg2_wells); 
  } 
  else{ 
 163
      ed1 = e1.run_exp(stg1_wells,stg2_wells); 
      ed2 = e1.run_exp(stg1_wells,stg2_wells); 
  }       
   
  if(sm_eval){ 
      count_e1[d] = ed1.getSMFound(); 
      count_e2[d] = ed2.getSMFound(); 
      count_fp1[d] = ed1.getSMFalsePos(); 
      count_fp2[d] = ed2.getSMFalsePos(); 
      count_fn1[d] = ed1.getSMFalseNeg(); 
      count_fn2[d] = ed2.getSMFalseNeg(); 
      printout1 = ed1.getPrintout(); 
      printout2 = ed2.getPrintout(); 
  } 
  else if(gt_eval){ 
      count_e1[d] = ed1.getSMFound(); 
      count_e2[d] = ed2.getSMFound(); 
      count_fp1[d] = ed1.getSMFalsePos(); 
      count_fp2[d] = ed2.getSMFalsePos(); 
      count_fn1[d] = ed1.getSMFalseNeg(); 
      count_fn2[d] = ed2.getSMFalseNeg(); 
      printout1 = ed1.getPrintout(); 
      printout2 = ed2.getPrintout(); 
  } 
  else{ 
      mean_e1[d] = ed1.getMean(); 
      sd_e1[d] = ed1.getStdDev(); 
      min_e1[d] = ed1.getMin(); 
      max_e1[d] = ed1.getMax(); 
      mean_e2[d] = ed2.getMean(); 
      sd_e2[d] = ed2.getStdDev(); 
      min_e2[d] = ed2.getMin(); 
      max_e2[d] = ed2.getMax(); 
      printout1 = ed1.getPrintout(); 
      printout2 = ed2.getPrintout(); 
  } 
   
     }//for(d) 
 
 
     if(sm_eval){ 
  double mean1 = MathHelper.mean(count_e1); 
  double sd1 = MathHelper.standardDeviation(count_e1, mean1); 
  double fp1 = MathHelper.mean(count_fp1); 
  double fn1 = MathHelper.mean(count_fn1); 
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  double mean2 = MathHelper.mean(count_e2); 
  double sd2 = MathHelper.standardDeviation(count_e2, mean2); 
  double fp2 = MathHelper.mean(count_fp2); 
  double fn2 = MathHelper.mean(count_fn2); 
      
  pw.println("Counting number of supermutants found"); 
  pw.println("First " + num_exps + " simulations"); 
  pw.println("  Mean:  "+ mean1); 
  pw.println("  S.Dev: "+ sd1); 
  pw.println("  F.Pos: "+ fp1); 
  pw.println("  F.Neg: "+ fn1); 
  pw.println(""); 
  pw.println("Second " + num_exps + " simulations"); 
  pw.println("  Mean:  "+ mean2); 
  pw.println("  S.Dev: "+ sd2); 
  pw.println("  F.Pos: "+ fp2); 
  pw.println("  F.Neg: "+ fn2); 
  pw.println(""); 
  pw.println("-----------------------"); 
  pw.println(""); 
  pw.println(""); 
  if(print_all){ 
      pw.println(""); 
      pw.println(printout1); 
      pw.println(""); 
      pw.println(printout2); 
  } 
     } 
     else if(gt_eval){ 
  double mean1 = MathHelper.mean(count_e1); 
  double sd1 = MathHelper.standardDeviation(count_e1, mean1); 
  double fp1 = MathHelper.mean(count_fp1); 
  double fn1 = MathHelper.mean(count_fn1); 
 
  double mean2 = MathHelper.mean(count_e2); 
  double sd2 = MathHelper.standardDeviation(count_e2, mean2); 
  double fp2 = MathHelper.mean(count_fp2); 
  double fn2 = MathHelper.mean(count_fn2); 
 
  pw.println("Counting number of bugs with activity greater " 
      + "than " + min_act); 
  pw.println("First " + num_exps + " simulations"); 
  pw.println("  Mean:  "+ mean1); 
  pw.println("  S.Dev: "+ sd1); 
  pw.println("  F.Pos: "+ fp1); 
  pw.println("  F.Neg: "+ fn1); 
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  pw.println(""); 
  pw.println("Second " + num_exps + " simulations"); 
  pw.println("  Mean:  "+ mean2); 
  pw.println("  S.Dev: "+ sd2); 
  pw.println("  F.Pos: "+ fp2); 
  pw.println("  F.Neg: "+ fn2); 
  pw.println(""); 
  pw.println("-----------------------"); 
  pw.println(""); 
  pw.println(""); 
  if(print_all){ 
      pw.println(""); 
      pw.println(printout1); 
      pw.println(""); 
      pw.println(printout2); 
  } 
     } 
     else{ 
 
  double mean1 = MathHelper.mean(mean_e1); 
  double sd1 = MathHelper.mean(sd_e1); 
  double min1 = MathHelper.mean(min_e1); 
  double max1 = MathHelper.mean(max_e1); 
 
  double mean2 = MathHelper.mean(mean_e2); 
  double sd2 = MathHelper.mean(sd_e2); 
  double min2 = MathHelper.mean(min_e2); 
  double max2 = MathHelper.mean(max_e2); 
   
  pw.println("Evaluating top " + top_pct + "% of wells"); 
  pw.println("First " + num_exps + " simulations"); 
  pw.println("  Mean:  "+ mean1); 
  pw.println("  S.Dev: "+ sd1); 
  pw.println("  Max: "+ max1); 
  pw.println("  Min: "+ min1); 
  pw.println(""); 
  pw.println("Second " + num_exps + " simulations"); 
  pw.println("  Mean:  "+ mean2); 
  pw.println("  S.Dev: "+ sd2); 
  pw.println("  Max: "+ max2); 
  pw.println("  Min: "+ min2); 
  pw.println(""); 
  if(print_all){ 
      pw.println(""); 
      pw.println(printout1); 
      pw.println(""); 
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      pw.println(printout2); 
  } 
  pw.println("-----------------------"); 
  pw.println(""); 
  pw.println(""); 
     } 
     pw.close(); 
     fw.close(); 
 }catch(Exception e){ 
     e.printStackTrace(); 
 }finally{ 
     try{ 
  pw.close(); 
     }catch(Exception e2){/*do nothing*/ } 
 }//finally 
     
    }//run_main() 
 
    /** 
     * Used to optimize plates used in each stage of DE. 
     * 
     * NOTE - Need to update this method for structural changes made. 
     * 
     * @param total_plates Total # of plates available. 
     * @param plate_size Number of wells per plate. 
     * @param cd CellDistribution to use for experiments. 
     * @param ad ActivityDistribution to use for experiments. 
     * @param output_file Name of file to write to. 
     */ 
    public static void optimizePlates(int total_plates,  
          int plate_size, 
          CellDistribution cd,  
          ActivityDistribution ad, 
          String output_file){ 
 
 FileWriter fw = null; 
 PrintWriter pw = null; 
 
 ExpData ed = null; 









 int num_exps = 50; 
 int num_rounds = 10; 
 int upper_plates; 
 int lower_plates; 
 double upper_mean; 
 double lower_mean; 
  
 double[] sd = new double[num_exps]; 
 double[] mean = new double[num_exps]; 
 
 int[] plates = new int[num_rounds]; 
 double[] sd_results = new double[num_rounds]; 
 double[] mean_results = new double[num_rounds]; 
 
 //start at top 
 int stg1_plates = total_plates - 1; 
 int stg2_plates = 1; 
 upper_plates = stg1_plates; 
 
 for(int d=0; d < num_exps; d++){ 
     ed = e1.run_exp(stg1_plates*plate_size,stg2_plates*plate_size); 
     sd[d] = ed.getStdDev(); 
     mean[d] = ed.getMean(); 
      
 }//for(d) 
  
 plates[0] = stg1_plates; 
 sd_results[0] = MathHelper.mean(sd); 
 mean_results[0] = MathHelper.mean(mean); 
 upper_mean = mean_results[0]; 
 
  
 //check bottom 
 stg1_plates = (int)(.5 * total_plates); 
 stg2_plates = total_plates - stg1_plates; 
 lower_plates = stg1_plates; 
  
 for(int d=0; d < num_exps; d++){ 
     ed = e1.run_exp(stg1_plates*plate_size,stg2_plates*plate_size); 
     sd[d] = ed.getStdDev(); 
     mean[d] = ed.getMean(); 
      
 }//for(d) 
  
 plates[1] = stg1_plates; 
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 sd_results[1] = MathHelper.mean(sd); 
 mean_results[1] = MathHelper.mean(mean); 
 lower_mean = mean_results[1]; 
 
 for(int i=2; i < num_rounds; i++){ 
      
     stg1_plates = (upper_plates + lower_plates)/2; 
     stg2_plates = total_plates - stg1_plates; 
 
     for(int d=0; d < num_exps; d++){ 
  ed = e1.run_exp(stg1_plates*plate_size,stg2_plates*plate_size); 
  sd[d] = ed.getStdDev(); 
  mean[d] = ed.getMean(); 
   
     }//for(d) 
 
     plates[i] = stg1_plates; 
     sd_results[i] = MathHelper.mean(sd); 
     mean_results[i] = MathHelper.mean(mean); 
      
     if(upper_mean > lower_mean){ 
  lower_mean = mean_results[i]; 
  lower_plates = stg1_plates; 
     } 
     else { 
  upper_mean = mean_results[i]; 
  upper_plates = stg1_plates; 




     fw = new FileWriter(output_file, true); 
     pw = new PrintWriter(fw); 
 
     pw.println("Plate Optimizer"); 
     pw.println("Bisectional search"); 
     pw.println(""); 
     //pw.println("CPW = " + cpw); 
     pw.println("Total Plates = " + total_plates); 
     pw.println(""); 
     pw.println("Stage1    StdDev    Mean"); 
     for(int i = 0; i < num_rounds; i++) { 
  pw.println("  " + plates[i] + "     " + 
      MathHelper.formatDouble(sd_results[i], 3) + "   " + 
      MathHelper.formatDouble(mean_results[i], 3)); 
     }//for(i) 
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     pw.println(""); 
     pw.println(""); 
     pw.println("*********************"); 
     pw.println(""); 
     pw.println(""); 
     pw.close(); 
 }//try 
 catch(Exception e){ 
     e.printStackTrace(); 
 } 
 finally{ 
     try{ 
  pw.close(); 
     }catch(Exception e2){ 
  e2.printStackTrace(); 
     } 
 } 
 
    }//optimizePlates(int,int,CellDistribution,ActivityDistribution,String) 
 
 
    public static long getTime(){ 
 return System.currentTimeMillis(); 
    } 
 
    public static long getMemoryKB(){ 
 Runtime.getRuntime().gc(); 
 long max = Runtime.getRuntime().totalMemory(); 
 long r = Runtime.getRuntime().freeMemory(); 
 return (max - r)/1024; 
    } 
 
 
    public static void run_main_infile(String filename){ 
 ActivityDistribution act_dist = null; 
        int act_ratio = 0; 
 double sm_ratio = 0.0; 
 double sm_percent = 0.0; 
 double assay_acc = 0.0; 
 double top_percent = 0.0; 
 double min_act = 0.0; 
 boolean supermutant = false; 
 boolean print_all = false; 
 boolean greater_than = false; 
 int num_plates = 0; 
 int plate_size = 0; 
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 int cells_per_well = 0; 
 int num_exps = 0; 
 double[] act_bins; 
 double[] pct_bins; 
 String output_file = null; 
 
 File infile; 
 FileReader fr; 
 BufferedReader br; 
 StringTokenizer st; 
 
 try{ 
     infile = new File(filename); 
     fr = new FileReader(infile); 
     br = new BufferedReader(fr); 
      
     st = new StringTokenizer(br.readLine()); 
     st.nextToken(); 
     output_file = st.nextToken(); 
 
     st = new StringTokenizer(br.readLine()); 
     st.nextToken(); 
     num_exps = Integer.parseInt(st.nextToken()); 
      
     st = new StringTokenizer(br.readLine()); 
     st.nextToken(); 
     num_plates = Integer.parseInt(st.nextToken()); 
 
     st = new StringTokenizer(br.readLine()); 
     st.nextToken(); 
     plate_size = Integer.parseInt(st.nextToken()); 
      
     st = new StringTokenizer(br.readLine()); 
     st.nextToken(); 
     assay_acc = Double.parseDouble(st.nextToken()); 
 
     st = new StringTokenizer(br.readLine()); 
     st.nextToken(); 
     cells_per_well = Integer.parseInt(st.nextToken()); 
 
     st = new StringTokenizer(br.readLine()); 
     st.nextToken(); 
     String temp = st.nextToken(); 
     if(temp.equals("SUPERMUTANT")){ 
  act_ratio = Integer.parseInt(st.nextToken());   
  supermutant = true; 
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  greater_than = false; 
  if(st.hasMoreTokens()) 
      if(st.nextToken().equals("PRINT_ALL")) 
   print_all = true; 
     } 
 
     else if(temp.equals("TOP_PCT")){ 
  top_percent = Double.parseDouble(st.nextToken()); 
  supermutant = false; 
  greater_than = false; 
  if(st.hasMoreTokens()) 
      if(st.nextToken().equals("PRINT_ALL")) 
   print_all = true; 
     } 
     else if(temp.equals("GREATER_THAN")){ 
  min_act = Double.parseDouble(st.nextToken()); 
  supermutant = false; 
  greater_than = true; 
  if(st.hasMoreTokens()) 
      if(st.nextToken().equals("PRINT_ALL")) 
   print_all = true; 
     } 
 
 
     /*GET ACTIVITY CURVE*/ 
     st = new StringTokenizer(br.readLine()); 
     st.nextToken(); 
     temp = st.nextToken(); 
     if(temp.equals("SUPERMUTANT")){ 
   
  st = new StringTokenizer(br.readLine()); 
  st.nextToken(); 
  act_ratio = Integer.parseInt(st.nextToken()); 
   
  st = new StringTokenizer(br.readLine()); 
  st.nextToken(); 
  sm_ratio = Double.parseDouble(st.nextToken()); 
  sm_percent = 1.0/sm_ratio; 
  act_dist = new SuperMutantDistribution(act_ratio,sm_percent); 
     } 
     else if(temp.equals("BINS")){ 
  int num_bins = Integer.parseInt(st.nextToken()); 
  act_bins = new double[num_bins]; 
  pct_bins = new double[num_bins]; 
 
  for(int i=0; i < num_bins; i++){ 
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      st = new StringTokenizer(br.readLine()); 
      act_bins[i] = Double.parseDouble(st.nextToken()); 
      pct_bins[i] = Double.parseDouble(st.nextToken()); 
  } 
 
  act_dist = new BinDistribution(pct_bins,act_bins); 
     } 
 
      
     st = null; 
     br.close(); 
      
     run_main(act_dist, act_ratio, assay_acc, sm_percent, num_plates, 
       plate_size, cells_per_well, output_file, num_exps,  
       supermutant, top_percent, print_all, greater_than, 
       min_act); 
 
 }catch(Exception e){ 
     e.printStackTrace(); 
 }  
 
    }//run_main_infile(String) 
         
    /****************************************/ 
    /************ MAIN METHOD ***************/ 
    /****************************************/     
     
    /** 
     * Main method - currently running supermutant experiments. 
     *  
     * @param argv Array of command line arguments. 
     */ 
    public static void main(String argv[]){ 
 
 if(argv.length > 0 ) 
     run_main_infile(argv[0]); 
 else{ 
     System.out.println("Usage: java Experiment <file name>"); 
     System.out.println("Input file should be plain text, see"+ 
          " in_example.txt"); 
 } 
  
    }//main(String[]) 
 
}//class Experiment 
 
